1,314 results on '"Jay, N"'
Search Results
2. Long term outcomes in older trauma patients admitted to the ICU: A prospective study
- Author
-
L.D. Britt, Michael Martyak, Jessica Burgess, Sasha White, Daisy M Proksch, Katherine M. Kelley, Jiangtao Luo, and Jay N. Collins
- Subjects
medicine.medical_specialty ,Inpatient mortality ,business.industry ,Mortality rate ,Psychological intervention ,General Medicine ,Middle Aged ,Hospitalization ,Intensive Care Units ,Injury Severity Score ,Severe trauma ,Surveys and Questionnaires ,Cohort ,Emergency medicine ,Long term outcomes ,Humans ,Medicine ,Surgery ,In patient ,Hospital Mortality ,Prospective Studies ,Prospective cohort study ,business ,Aged - Abstract
Background Prior studies have shown an increase in mortality in elderly patients when compared to their younger cohort. Methods Level 1 trauma patients ≥50 years old were recruited upon admission to the ICU and prospectively followed. After an initial survey, inpatient data were collected and phone surveys were completed at 3 and 6 months. Results 100 patients were included. There was an 18% inpatient mortality. At 6 months, the mortality rate was 24%; 73% of surviving patients reported good health. 6-month nonsurvivors had a higher percentage requiring preinjury assistance with ambulation. Conclusions Severe trauma in patients ≥50 years of age carries a significant rate of mortality however survivors have good outcomes. Need for assistance with ambulation prior to injury is associated with 6 month mortality and could be used as a screening tool for interventions.
- Published
- 2022
- Full Text
- View/download PDF
3. RESEARCH ORIENTED MEDICAL SCHOOL CURRICULA TO NURTURE UNDERGRADUATES IN PREPARATION FOR THE FUTURE PHYSICIAN SCIENTISTS: RELEVANCE FOR DEVELOPING COUNTRIES
- Author
-
Harish Chandra Neupane, Jay N Shah, Gehanath Baral, and Ganesh Dangal
- Subjects
Medical education ,business.industry ,Medical school ,Developing country ,Medicine ,Relevance (information retrieval) ,business ,Curriculum ,Nature versus nurture - Abstract
N/A
- Published
- 2021
- Full Text
- View/download PDF
4. Author-level metrics: Its impact on scholarly output evaluation among various publication metrics
- Author
-
Jay N Shah
- Subjects
Measure (data warehouse) ,Information retrieval ,Index (publishing) ,business.industry ,Computer science ,The Internet ,Metric (unit) ,Scientometrics ,Bibliometrics ,business ,Citation ,Complement (set theory) - Abstract
Publication metrics indicate the visibility and reach of a research publication. The metrics can be at article-level, author-level, and journal-level to measure the scholarly output and its impact.1 Bibliometrics is the use of statistical methods to analyze various publications mostly used in the field of library and information science; whereas, scientometrics is the sub-field concerned with the science of metrics for the measurement and analysis of scholarly publications.2,3 Readers are not always well informed about the various publication metrics, and use them without knowing how to interpret them, their strength and limitations.4,5 The Internet has revolutionized the dissemination, visibility, and impact of documented evidence available on the Web. The author-level metrics (ALmetrics) provides a measure for the research output of an individual author.6 It summarizes and aggregates the impact of an author's publications by using metrics like h-index (Hirsch-index7, calculated from the number of articles N by an author that have each received at least N citations), i10-index (measures the number of publications with at least 10 citations, Google Scholar), g-index (an improvement of h-index by giving more weight to highly-cited articles), e-index (differentiates between scientists with similar h-indices but different citation patterns) and others.8 The h-index (proposed by J.E. Hirsch in 2005) is a well-accepted metric to assess the scientific impact of an individual author and/or institution due to its simplicity for cumulative research output to indicate a number of papers (h) with at least h citations, e.g. h-index 9 means that among all publications by an author, 9 publications have at least 9 citations each.9,10 Various other new additions are proposed to complement the h-index to minimize its shortcomings in calculations of the index due to co-authors, self/collaborative citation, publication age, publication count, etc.11 The h-core is a contextualized evaluation considered more useful.12 Combination of newer variants help complement and eliminate some of the limitations of h-index, for example, R-index (to measure citation intensity of h-score) and AR-index (to include the age of publications).13 14 The w-index is another simple and useful improvement to the h-index to assess the integrated impact of a researcher's work.15 The rh-index (robust h-index) adds value for the self- and collaborative citation.16
- Published
- 2021
- Full Text
- View/download PDF
5. Breakthrough infection after Covishield COVID-19 vaccine among health care workers at Patan Academy of Health Sciences, Nepal
- Author
-
Shanta Dangol Shrestha, Ashis Shrestha, Nabees Ms Pradhan, Priscilla Samson, Jay N Shah, Shreekrishna Maharjan, and Sarala Kc
- Subjects
medicine.medical_specialty ,Coronavirus disease 2019 (COVID-19) ,business.industry ,virus diseases ,Breakthrough infection ,Vaccination ,Immunization ,Vaccination status ,Family medicine ,Health care ,Pandemic ,medicine ,business ,Biomedical sciences - Abstract
Introduction: Coronavirus Disease 2019 (COVID-19) vaccines have an important role in the control and prevention of the pandemic. However, infection after vaccination, though uncommon, has been reported after partial or complete immunization. This study aims to find out vaccine breakthrough infection after the administration of the Covishield COVID-19 vaccine. Method: This cross-sectional survey was conducted among the health care workers (HCWs) from May 2021 to July 2021 at Patan Hospital, Patan Academy of Health Sciences, Nepal who received the Covishield vaccine. The data were collected using Google form and a printed questionnaire on COVID 19 breakthrough infection ≥2w after vaccination. The rate of breakthrough infection, hospitalization, and its association with age, gender, and working departments of HCWs was analyzed using SPSS. Ethical approval was obtained. Result: Out of 1462 HCWs approached, 880 completed the survey, among which 819(93.1%) had a completed vaccination status. Infection after the first and before the second dose was 164(18.7% of 880) and after two doses 131(16%). The breakthrough infection occurred in 83 (10.1% of 819). There was no statistically significant association of breakthrough infection with age, gender, and working department of HCWs. Total 74(8.4%) were managed by admission in hospital. Conclusion: The findings of this study reveal a low breakthrough infection rate after Covishield vaccination among HCWs at Patan Academy of Health Sciences, Kathmandu, Nepal. Overall, COVID-19 infection rates decreased after the first and second dose of the vaccine. Keywords: Breakthrough infection, Covishield COVID-19 vaccine, reinfection
- Published
- 2021
- Full Text
- View/download PDF
6. NT-proBNP for Risk Prediction in Heart Failure
- Author
-
M. Lund, Hean Yee Ong, Roberto Latini, Gerry Devlin, Robert N. Doughty, Francesco Gentile, Fazlur Jaufeerally, A. Mark Richards, Thor Ueland, Laura M G Meems, Antoni Bayes-Genis, Poh Shuah Daniel Yeo, Alberto Giannoni, Kai M. Eggers, Giuseppe Vergaro, Akiomi Yoshihisa, Hanna K. Gaggin, Josep Lupón, Richard W. Troughton, Kurt Huber, Lidia Staszewsky, Tze P. Ng, Ida Gustafsson, Lars Gullestad, Hans-Peter Brunner-La Rocca, Kui Tong Gerard Leong, Jay N. Cohn, Inder S. Anand, Michael Egstrup, Carolyn S.P. Lam, Alberto Aimo, Yasuchika Takeishi, Pål Aukrust, Michele Emdin, Greg D. Gamble, Claudio Passino, James L. Januzzi, Rudolf A. de Boer, and Lieng H. Ling
- Subjects
medicine.medical_specialty ,medicine.drug_class ,business.industry ,Internal medicine ,Heart failure ,medicine ,Natriuretic peptide ,Cardiology ,Cardiology and Cardiovascular Medicine ,medicine.disease ,Brain natriuretic peptide ,business ,Body mass index - Abstract
Objectives The goal of this study was to assess the predictive power of N-terminal pro–B-type natriuretic peptide (NT-proBNP) and the decision cutoffs in heart failure (HF) across body mas...
- Published
- 2021
- Full Text
- View/download PDF
7. Re-appraisal of the obesity paradox in heart failure
- Author
-
Giuseppe Vergaro, Yasuchika Takeishi, Ida Gustafsson, Inder S. Anand, Kai M. Eggers, Michael Egstrup, Aldo Clerico, Andrea Ripoli, Jay N. Cohn, Jennifer Meessen, Nick Marcks, Akiomi Yoshihisa, Claudio Passino, Hanna K. Gaggin, Alberto Aimo, Thor Ueland, Michele Emdin, Josep Lupón, Roberto Latini, James L. Januzzi, Antoni Bayes-Genis, Sandra Sanders-van Wijk, Ioannis Tentzeris, Rudolf A. de Boer, Jørgen Gravning, Kurt Huber, Hans-Peter Brunner-La Rocca, Cardiologie, RS: Carim - H02 Cardiomyopathy, MUMC+: MA Med Staf Spec Cardiologie (9), and Cardiovascular Centre (CVC)
- Subjects
medicine.medical_specialty ,medicine.drug_class ,IMPACT ,Population ,Heart failure ,Comorbidity ,030204 cardiovascular system & hematology ,DISEASE ,03 medical and health sciences ,0302 clinical medicine ,Internal medicine ,Natriuretic Peptide, Brain ,Natriuretic peptide ,medicine ,Humans ,TROPONIN-T ,Biomarkers ,Body mass index ,Co-morbidities ,Disease severity ,Obesity ,Cardiac and Cardiovascular Systems ,030212 general & internal medicine ,education ,RISK ,Original Paper ,education.field_of_study ,Ejection fraction ,Kardiologi ,business.industry ,MORTALITY ,Age Factors ,Stroke Volume ,General Medicine ,Prognosis ,medicine.disease ,Peptide Fragments ,Troponin ,BODY-MASS INDEX ,FAT ,Meta-analysis ,Cardiology ,Cardiology and Cardiovascular Medicine ,business ,Obesity paradox - Abstract
Background Higher body mass index (BMI) is associated with better outcome compared with normal weight in patients with HF and other chronic diseases. It remains uncertain whether the apparent protective role of obesity relates to the absence of comorbidities. Therefore, we investigated the effect of BMI on outcome in younger patients without co-morbidities as compared to older patients with co-morbidities in a large heart failure (HF) population. Methods In an individual patient data analysis from pooled cohorts, 5,819 patients with chronic HF and data available on BMI, co-morbidities and outcome were analysed. Patients were divided into four groups based on BMI (i.e. ≤ 18.5 kg/m2, 18.5–25.0 kg/m2; 25.0–30.0 kg/m2; 30.0 kg/m2). Primary endpoints included all-cause mortality and HF hospitalization-free survival. Results Mean age was 65 ± 12 years, with a majority of males (78%), ischaemic HF and HF with reduced ejection fraction. Frequency of all-cause mortality or HF hospitalization was significantly worse in the lowest two BMI groups as compared to the other two groups; however, this effect was only seen in patients older than 75 years or having at least one relevant co-morbidity, and not in younger patients with HF only. After including medications and N-terminal pro-B-type natriuretic peptide and high-sensitivity cardiac troponin concentrations into the model, the prognostic impact of BMI was largely absent even in the elderly group with co-morbidity. Conclusions The present study suggests that obesity is a marker of less advanced disease, but does not have an independent protective effect in patients with chronic HF. Graphic abstract Categories of BMI are only predictive of poor outcome in patients aged > 75 years or with at least one co-morbidity (bottom), but not in those aged
- Published
- 2021
- Full Text
- View/download PDF
8. Obturator hernia: a case report
- Author
-
Madiha Aziz, Jay N. Collins, and C. Kendall Major
- Subjects
medicine.medical_specialty ,Hernia ,Signs and symptoms ,Medial compartment of thigh ,Abdominal wall ,03 medical and health sciences ,0302 clinical medicine ,Laparoscopic ,Surgical oncology ,Intestine, Small ,Case report ,medicine ,Humans ,030212 general & internal medicine ,Obturator hernia ,General surgery ,Aged, 80 and over ,Small bowel resection ,business.industry ,Abdominal Wall ,Hernia, Obturator ,General Medicine ,medicine.disease ,digestive system diseases ,Surgery ,Bowel obstruction ,medicine.anatomical_structure ,030220 oncology & carcinogenesis ,Medicine ,Female ,Laparoscopy ,business ,Intestinal Obstruction - Abstract
Background Obturator hernia is rare and accounts for less than 1% of all abdominal wall hernias. It represents a diagnostic challenge due to its nonspecific signs and symptoms. Case presentation We present a case of an 89-year-old caucasian female with a 12-hour history of right medial thigh pain. Computed tomography scan revealed a right obturator hernia with small bowel obstruction. The hernia was successfully repaired laparoscopically without any need for small bowel resection. She was discharged on postoperative day 2 with an uneventful recovery and zero complications. Conclusion This case report highlights the importance of rapid diagnosis and repair of obturator hernia even in the setting of an improving clinical picture. It also demonstrates the safety of laparoscopic repair in this setting.
- Published
- 2021
9. Utility of Neutrophil to Lymphocyte ratio and platelet to lymphocyte ratio as early predicter of severe acute biliary pancreatitis
- Author
-
Shailendra Shah, Sanjaya Paudyal, Surendra Shah, Jay N Shah, and Shanta Bir Maharjan
- Subjects
medicine.medical_specialty ,business.industry ,Lymphocyte ,macromolecular substances ,acute biliary pancreatitis ,organ failure ,neutrophil to lymphocyte ratio ,platelet to lymphocyte ratio ,Gastroenterology ,medicine.anatomical_structure ,Internal medicine ,Medicine ,Platelet ,Biliary pancreatitis ,Neutrophil to lymphocyte ratio ,business - Abstract
Introduction: Acute severe pancreatitis is associated with increased mortality. Several scoring systems have been used to predict severe acute pancreatitis which are either time-consuming or calculated 48 hours after admission. This study was aimed to assess the utility of neutrophils to lymphocyte ratio and platelet to lymphocyte ratio as an early predictor of severe acute biliary pancreatitis.Materials and Methods: This was a retrospective cohort study conducted from January 2017 to January 2020. Patients with non-biliary pancreatitis, referred after initial treatment, missed data, and acute pancreatitis with acute cholecystitis or cholangitis were excluded from the study. Data were collected from case sheets. Patients were divided into two groups according to the development of severe acute biliary pancreatitis based on the revised Atlanta Classification. Association of neutrophil to lymphocyte ratio and platelet to lymphocyte ratio with severe acute biliary pancreatitis was assessed using Mann Whitney U-test. p-value < 0.05 was considered as statistically significant.Results: Total 73 cases included in the study (males/females= 0.55). Sixty-six patients (90.4%) had mild/moderate acute biliary pancreatitis, and 7 (9.6%) patients had severe acute biliary pancreatitis. There was a development of complications in 7 (9.6%) patients who had severe acute biliary pancreatitis including one mortality. The mean neutrophil to lymphocyte ratio and mean platelet to lymphocyte ratio were high in the severe acute biliary pancreatitis group compared to the nonsevere acute biliary pancreatitis group, however, these differences were not statistically significant.Conclusions: Neutrophil to lymphocyte ratio and platelet to lymphocyte ratio cannot predict severe acute biliary pancreatitis.
- Published
- 2021
10. Breakthrough infection after COVID-19 vaccination: A threat for Nepal due to SARS-CoV-2 variants circulating in 2nd wave ravaging India
- Author
-
Ashis Shrestha, Jenifei Shah, Sarala Kc, Jesifei Shah, Nabees Man Singh Pradhan, Jay N Shah, Shreekrishna Maharjan, and Priscilla Samson
- Subjects
education.field_of_study ,business.industry ,Incidence (epidemiology) ,Population ,virus diseases ,Breakthrough infection ,Virology ,Vaccination ,Immunization ,Immunity ,parasitic diseases ,Pandemic ,Medicine ,education ,business ,Adverse effect - Abstract
After a year of the COVID-19 pandemic, the meta-analysis in Dec 2020 did not support its reinfections. Now it is clear that not only reinfection following earlier exposure is a reality, but also breakthrough infections after vaccinations have been increasingly reported. A breakthrough infection means that the infection has broken through the protection provided by the vaccine. The course of the disease, strict observation for preventive measures, together with safe vaccines is necessary for long-term solutions. The effectiveness of the vaccine, durability of immunity, the role of the virus variants, the incidence and severity of breakthrough infections are the challenges in real life. A breakthrough infection is the detection of SARS-CoV-2 RNA or antigen in the respiratory specimen ≥14 days after inoculation of a vaccine. A breakthrough infection of 0.04 to 13% has been reported in the literature. Nepal began vaccine rollout in late Jan 2021. Nearly 3 million population has been vaccinated by two vaccines, the Covishield (AstraZeneca, from India) and Vero Cell (Sinopharm, China). Only minor ‘Adverse Event Following Immunization’ after the initial vaccine rollout has been reported. There is a lack of reports on the breakthrough infection for these vaccines in the local population. Analysis of the data on breakthrough infection from the vaccine rollouts in Nepal is awaited. Keywords: breakthrough infection, COVID-19 vaccine, Nepal, SARS-CoV-2 variants, 2nd wave
- Published
- 2021
- Full Text
- View/download PDF
11. Lymphadenectomy Around Inferior Mesenteric Artery in Low-Tie vs High-Tie Laparoscopic Anterior Resection: Short- and Long-Term Outcome of a Cohort of 614 Rectal Cancers
- Author
-
Ming Zhong, Ran Jing, Yang Luo, Shao-Lan Qin, Jay N Shah, Jun Qin, Yi-Zhou Huang, and Min-Hao Yu
- Subjects
0301 basic medicine ,Left colic artery ,medicine.medical_specialty ,Colorectal cancer ,medicine.medical_treatment ,left colic artery ,laparoscopic anterior resection ,anastomotic leakage ,Inferior mesenteric artery ,03 medical and health sciences ,low-tie high-tie of the inferior mesenteric artery ,0302 clinical medicine ,medicine.artery ,medicine ,rectal cancer ,Lymph node ,Original Research ,business.industry ,Clavien-Dindo complications ,medicine.disease ,Surgery ,Dissection ,030104 developmental biology ,medicine.anatomical_structure ,Oncology ,Cancer Management and Research ,030220 oncology & carcinogenesis ,Cohort ,Lymphadenectomy ,business ,Cohort study - Abstract
Yang Luo,1,* Min-Hao Yu,1,* Yi-Zhou Huang,1 Ran Jing,1 Jun Qin,1 Shao-Lan Qin,1 Jay N Shah,1,2 Ming Zhong1 1Department of Gastrointestinal Surgery, Renji Hospital, Jiao Tong University School of Medicine, Shanghai, 200127, People’s Republic of China; 2Department of Surgery, Patan Hospital, Patan Academy of Health Sciences, Lalitpur, Kathmandu, 44700, Nepal*These authors contributed equally to this workCorrespondence: Ming Zhong; Jay N Shah Email drzhongming@hotmail.com; drjaywufei@gmail.comBackground: Preservation of the left colic artery in low-tie (LT) of inferior mesenteric artery remains controversial compared to high-tie (HT) in the colon and rectal cancers, for lymph node dissection, anastomotic leakage, and oncological outcome. This cohort study aims to analyze short- and long-term outcomes of laparoscopic anterior resections in LT vs HT for rectal cancers.Methods: We analyzed a cohort of laparoscopic AR for RC from 2013 to 2016 at Renji Hospital, Shanghai, China. Short- and long-term outcome in LT vs HT group were compared for clinico-demographic characteristics, operative-time, lymph node dissection, short-term 30-day outcome, and long-term 3- and 5-year overall survival as well as disease-free survival. The x2, t-test, and logistic regressions analysis were used and p< 0.05 was considered significant.Results: The cohort consisted of 614 laparoscopic AR with LT (236) and HT (378). The clinicodemographic characteristics were comparable among the groups. The surgery took longer in LT. The yield of LND was similar. Leakage occurred in 12.21% (n=75). Leakage was fewer in LT than HT, 8.89% vs 14.28%, p=0.047. The postoperative severe complications were higher in HT. The 30-day mortality was nil. The long-term 3- and 5-year overall survival and disease-free survival were similar in LT and HT.Conclusion: The LT with preservation of left colic artery had similar lymph node yield, but lower leakage and complications than HT in laparoscopic anterior resections for rectal cancers. The long-term 3- and 5-year overall and disease-free survival were similar in the two groups.Keywords: anastomotic leakage, Clavien-Dindo complications, laparoscopic anterior resection, left colic artery, low-tie high-tie of the inferior mesenteric artery, rectal cancer
- Published
- 2021
12. Competency Based Post Graduate Residency Program at Patan Academy of Health Sciences, Nepal
- Author
-
Shrijana Shrestha, Rajesh Gongal, Jay N Shah, and Ashis Shrestha
- Subjects
Process (engineering) ,Teaching method ,MEDLINE ,Certification ,Unit (housing) ,Resource (project management) ,post graduate training ,ComputingMilieux_COMPUTERSANDEDUCATION ,Medicine ,Humans ,patan academy of health sciences ,Medical education ,business.industry ,Core competency ,Internship and Residency ,General Medicine ,competency based medical education ,nepal ,Leadership ,residency program ,Clinical Competence ,Faculty development ,Public aspects of medicine ,RA1-1270 ,business - Abstract
Competency-based medical education has evolved as an alternative approach in the residency training program. It shows potential to align educational programs with health system priorities through defining the competencies of graduating doctors. Designing and implementing Competency Based Post Graduate (CBPG) training in a resource-limited setting, where most of the trainings are still run in a conventional approach, is a big challenge. Patan Academy of Health Sciences, School of Medicine has taken the competency-based approach in the postgraduate residency training. Defining core competencies and connecting those to teaching methodology and assessment system are important initial steps in implementing the competency-based approach. The institution has implemented Entrustable Professional Activity (EPA), which is a unit of professional practice and helps to measure the trainees’ achievements in the form of milestones. This paper describes the process of piloting and implementing the CBPG program at this school.The school launched the CBPG training in 2018 and so far, three batches of residents have been enrolled in nine different subjects/disciplines. The first batch of trainee, having the PAHS Core competencies and the pre-defined discipline-specific EPAs certified, will be completing their training soon. The program is time and resource consuming. Continuous faculty development, commitment, supportive leadership and faculty readiness to adapt to newer approaches are the key to the program’s successful implementation.Keywords: Competency based medical education; Nepal; patan academy of health sciences; post graduate training; residency program
- Published
- 2021
13. Kawasaki Disease-Management Strategies Given Symptoms Overlap to COVID-19: A Review
- Author
-
Lei Ma, Li Xiaohong, Linna Wang, Mu Zhilong, Fuyong Jiao, Gaitao He, Jenifei Shah, Jay N Shah, Han Wei, Ji Ma, J Y Wang, Sheng Zhang, and Jing Ni
- Subjects
Pediatrics ,medicine.medical_specialty ,Medicine (General) ,Coronavirus disease 2019 (COVID-19) ,Disease ,Review Article ,Mucocutaneous Lymph Node Syndrome ,R5-920 ,children ,hemic and lymphatic diseases ,medicine ,Humans ,cardiovascular diseases ,Child ,skin and connective tissue diseases ,Coronary artery aneurysm ,Aspirin ,Kawasaki disease ,SARS-CoV-2 ,business.industry ,COVID-19 ,General Medicine ,medicine.disease ,Systemic Inflammatory Response Syndrome ,medicine.anatomical_structure ,Macrophage activation syndrome ,Vasculitis ,business ,medicine.drug ,Artery - Abstract
Kawasaki disease is an acute, self-limiting vasculitis in children. Early treatment is necessary to prevent cardiovascular complications. The acute phase of Kawasaki disease may present with hemodynamic instability. An association between viral respiratory infections and Kawasaki disease has been reported. Studies have shown that Kawasaki and Kawasaki-like disease may be associated with and have symptoms overlapping COVID-19. Children with COVID-19 may present as Kawasaki-like disease with pediatric inflammatory multisystem syndrome, or macrophage activation syndrome. Clinicians need to be aware of the early diagnosis and management of Kawasaki disease to prevent the development of coronary artery aneurysms. The symptoms overlap of multisystem inflammatory disease seen in COVID-19 adds to the difficulties in timely diagnosis and treatment. Children with Kawasaki disease require regular follow-up plans for coronary artery aneurysms. This adds to the difficulties during the changed environment of COVID-19 for control and prevention. Missed diagnosis and early treatment of Kawasaki disease with immunoglobulin and aspirin results in the development of coronary artery aneurysm in up to 25% of cases, with grave consequences. Here, we briefly review the management of typical and atypical Kawasaki disease which has symptoms overlapping with the multisystem inflammatory disease as seen in COVID-19.
- Published
- 2021
14. Outcomes of Trauma Patients with Flail Chest and Surgical Rib Stabilization
- Author
-
Michael Martyak, Reem Sharaf Alddin, Alexander P McNally, Jay N. Collins, Kyle Deivert, Colten A Yahn, and Tyler Fraga
- Subjects
medicine.medical_specialty ,Flail chest ,Rib Fractures ,business.industry ,medicine.medical_treatment ,Ribs ,General Medicine ,Length of Stay ,medicine.disease ,Surgery ,Fracture Fixation, Internal ,Flail Chest ,medicine ,Humans ,Intubation ,business ,Retrospective Studies ,Fixation (histology) - Abstract
The goal of this project was to describe the current practices of this institution and identify which patients benefit from surgical stabilization of rib fractures (SSRF). A total of 1429 trauma patients admitted to our Level 1 center with rib fractures between January 1, 2014 and June 22, 2020 were retrospectively reviewed. Flail chest was observed in 43 (3.01%) patients. Surgical stabilization of rib fractures was pursued in 27 of all patients (1.89%). Twenty-four flail chest patients required intubation (ETT). Nineteen were not intubated (NoET). Of the ETT group, 8 underwent SSRF and 16 did not. Those who had SSRF had a shorter ventilator Length of Stay (7.1 vs 15.7 d) and Intensive Care Unit Length of Stay (9.8 vs 11.9 d). Surgical stabilization of rib fractures has shown success in managing flail chest. In intubated patients with flail chest, fixation seems to decrease Intensive Care Unit stays and the duration of ventilation. We believe we need to perform SSRF on more patients with flail chest.
- Published
- 2021
- Full Text
- View/download PDF
15. Assessment of Psychological Comorbidities in Patients with Head and Neck Cancer as Compared to Other ENT Patients
- Author
-
Jay N. Suratwala, Varun Jitendra Dave, Ritambhara Y Mehta, Jaymin A. Contractor, Rahul B. Patel, Saumitra Nemlekar, and Ravi H Shah
- Subjects
medicine.medical_specialty ,Otorhinolaryngology ,business.industry ,Head and neck cancer ,medicine ,In patient ,medicine.disease ,business ,Surgery - Published
- 2021
- Full Text
- View/download PDF
16. The COVID-19 Pandemic and Public Support for European Integration: Evidence from Germany
- Author
-
Jay N. Krehbiel and Sivaram Cheruvu
- Subjects
Coronavirus disease 2019 (COVID-19) ,business.industry ,Political science ,Political economy ,European integration ,Pandemic ,Comparative politics ,Public opinion ,business ,Public support - Published
- 2021
- Full Text
- View/download PDF
17. Brain charts for the human lifespan
- Author
-
Armin Raznahan, Eric Courchesne, Andrea Parolin Jackowski, Kamen A. Tsvetanov, Cameron T. Ellis, R.C. Gur, Bin Bae J, Park Mtm, Pedro A. Valdes-Sosa, Simon N. Vandekar, Jacob W. Vogel, Juan Zhou, Machteld Marcelis, Kiho Im, Patricia Ellen Grant, Minhui Ouyang, Blesa Cabez M, Michael V. Lombardo, Sarah E. Morgan, James P. Boardman, Adamson C, Calhoun Vd, Delarue M, James H. Cole, Pichet Binette A, Roberto Toro, David H. Rowitch, Nynke A. Groenewold, Kevin M. Anderson, David T.W. Jones, Michael Schöll, Wang Ys, Aiden Corvin, R.E. Gur, Damien A. Fair, Gareth Ball, Herma Lina Schaare, Andrew Zalesky, Evdokia Anagnostou, Michael J. Meaney, Taki Y, Gareth J. Sullivan, Warrier, Petra E. Vértes, Chixiang Chen, Lisa T. Eyler, Wei Liao, Tomáš Paus, Jeremy A. Elman, Phillip McGuire, Hisham Ziauddeen, William S. Kremen, Etienne Vachon-Presseau, E.T. Bullmore, Christophe Tzourio, White, Hammill Cf, Mothersill D, Richard N. Henson, Jiang Qiu, Duncan E. Astle, Fabrice Crivello, Paul C. Fletcher, Chertavian C, Kim K, Jennifer Crosbie, Russell Schachar, Gabriel A. Devenyi, Manfred G. Kitzbichler, Tianye Jia, Trey Hedden, Sang Jae Lee, Ross D. Markello, Silke Kern, Ian M. Goodyer, Keith A. Johnson, Frauke Beyer, Bernard Mazoyer, A. Heinz, Sylvane Desrivières, Rosenberg, Gary Donohoe, Ong Mq, Alexander D. Edwards, Dan J. Stein, Nenad Medic, Zuo Xn, Travis T. Mallard, Peter Fonagy, Lindsay W. Victoria, Ingmar Skoog, Avram J. Holmes, Jason P. Lerch, Jed T. Elison, Jianfu Li, John H. Gilmore, Rosemary Holt, Caitlin K. Rollins, Carol E. Franz, Pedro Mario Pan, Saashi A Bedford, Yang N, Jonathan C Ipser, Richard A. I. Bethlehem, Tuulari Jj, Stolicyn A, Hua Huang, Bratislav Misic, Conor Liston, Ayub M, Lisa Ronan, Yeo Bt, Sophie Adler, Charles J. Lynch, Faith M. Gunning, Konrad Wagstyl, M. Mallar Chakravarty, John Suckling, Theodore D. Satterthwaite, Bharath Holla, Yap Seng Chong, Jinglei Lv, Jakob Seidlitz, Niall J Bourke, Xinlei Qian, Simon Baron-Cohen, Cynthia M. Ortinau, Deirel Paz Linares, Thyreau B, René S. Kahn, Aaron P. Schultz, Vanessa Cropley, Eric Westman, Mitchell Valdés-Sosa, Rik Ossenkoppele, André Zugman, Hasse Karlsson, Sylvia Villeneuve, Katja Heuer, Di Biase Ma, Margaret L. Westwater, Sofie L. Valk, David J. Sharp, Brigitte Landeau, Matthew Borzage, Kirsten A. Donald, Timothy Rittman, Richard Beare, Giovanni Abrahão Salum, Gunter Schumann, Ryuta Kawashima, Romero-Garcia R, John Blangero, Yun Hj, Russel T. Shinohara, Nicolas Crossley, Simon K. Warfield, Karen Pierce, George S. Alexopoulos, Katharine Dunlop, David C. Glahn, Francois Lalonde, Anqi Qiu, Lana Vasung, Gaël Chételat, Lídice Galán-García, Clifford R. Jack, Reisa A. Sperling, Anna Zettergren, Elizabeth Kelley, Arno Villringer, Andrea Mechelli, Benegal, Aaron Alexander-Bloch, Nicholas B. Turk-Browne, van Amelsvoort T, John D. Lewis, Heather C. Whalley, A. V. Witte, Zdenka Pausova, Joel T. Nigg, Heather J. Zar, Raymond J. Dolan, Christopher D. Smyser, Jay N. Giedd, Lena Palaniyappan, Ali Gholipour, Areces-Gonzalez A, Peter B. Jones, Jacqueline Hoare, Oskar Hansson, Linnea Karlsson, C Pantelis, Paly L, Bonnie Auyeung, Jorge Bosch-Bayard, Bethlehem, Richard [0000-0002-0714-0685], White, Simon [0000-0001-8642-7037], Astle, Duncan [0000-0002-7042-5392], Baron-Cohen, Simon [0000-0001-9217-2544], Henson, Rik [0000-0002-0712-2639], Jones, Peter [0000-0002-0387-880X], Kitzbichler, Manfred [0000-0002-4494-0753], Rittman, Timothy [0000-0003-1063-6937], Rowitch, David [0000-0002-0079-0060], Tsvetanov, Kamen A. [0000-0002-3178-6363], Westwater-Wozniak, Margaret [0000-0002-2918-0979], Ziauddeen, Hisham [0000-0003-4044-1719], Apollo - University of Cambridge Repository, British Academy, Autism Research Trust, National Institute of Mental Health (US), UK Research and Innovation, Medical Research Council (UK), National Institute for Health and Care Research (US), Wellcome Trust, University of Cambridge, Cambridge Biomedical Research Centre, University of Cambridge [UK] (CAM), University of Pennsylvania, Yale University [New Haven], Institut des Maladies Neurodégénératives [Bordeaux] (IMN), Université de Bordeaux (UB)-Centre National de la Recherche Scientifique (CNRS), Physiopathologie et imagerie des troubles neurologiques (PhIND), Université de Caen Normandie (UNICAEN), Normandie Université (NU)-Normandie Université (NU)-Institut National de la Santé et de la Recherche Médicale (INSERM), Génétique humaine et fonctions cognitives - Human Genetics and Cognitive Functions (GHFC (UMR_3571 / U-Pasteur_1)), Institut Pasteur [Paris] (IP)-Centre National de la Recherche Scientifique (CNRS)-Université Paris Cité (UPCité), Child and Adolescent Psychiatry Department [AP- HP Hôpital Robert Debré], AP-HP Hôpital universitaire Robert-Debré [Paris], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Département de Neuroscience - Department of Neuroscience, Centre de Recherche Interdisciplinaire / Center for Research and Interdisciplinarity [Paris, France] (CRI), Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Paris Cité (UPCité), Bordeaux population health (BPH), Université de Bordeaux (UB)-Institut de Santé Publique, d'Épidémiologie et de Développement (ISPED)-Institut National de la Santé et de la Recherche Médicale (INSERM), Psychiatrie & Neuropsychologie, RS: MHeNs - R2 - Mental Health, MUMC+: MA Med Staf Spec Psychiatrie (9), Neurology, Amsterdam Neuroscience - Neurodegeneration, 3R-BRAIN, AIBL, Alzheimer’s Disease Neuroimaging Initiative, Alzheimer’s Disease Repository Without Borders Investigators, CALM Team, Cam-CAN, CCNP, COBRE, cVEDA, ENIGMA Developmental Brain Age Working Group, Developing Human Connectome Project, FinnBrain, Harvard Aging Brain Study, IMAGEN, KNE96, The Mayo Clinic Study of Aging, NSPN, POND, The PREVENT-AD Research Group, VETSA, [Bethlehem, R. A. I.] Univ Cambridge, Dept Psychiat, Autism Res Ctr, Cambridge, England, [Auyeung, B.] Univ Cambridge, Dept Psychiat, Autism Res Ctr, Cambridge, England, [Baron-Cohen, S.] Univ Cambridge, Dept Psychiat, Autism Res Ctr, Cambridge, England, [Bedford, S. A.] Univ Cambridge, Dept Psychiat, Autism Res Ctr, Cambridge, England, [Holt, R.] Univ Cambridge, Dept Psychiat, Autism Res Ctr, Cambridge, England, [Lombardo, M. V.] Univ Cambridge, Dept Psychiat, Autism Res Ctr, Cambridge, England, [Bethlehem, R. A. I.] Univ Cambridge, Dept Psychiat, Brain Mapping Unit, Cambridge, England, [Kitzbichler, M. G.] Univ Cambridge, Dept Psychiat, Brain Mapping Unit, Cambridge, England, [Seidlitz, J.] Univ Penn, Dept Psychiat, Philadelphia, PA 19104 USA, [Vogel, J. W.] Univ Penn, Dept Psychiat, Philadelphia, PA 19104 USA, [Gur, R. E.] Univ Penn, Dept Psychiat, Philadelphia, PA 19104 USA, [Gur, R. C.] Univ Penn, Dept Psychiat, Philadelphia, PA 19104 USA, [Jackowski, A. P.] Univ Penn, Dept Psychiat, Philadelphia, PA 19104 USA, [Satterthwaite, T. D.] Univ Penn, Dept Psychiat, Philadelphia, PA 19104 USA, [Alexander-Bloch, A. F.] Univ Penn, Dept Psychiat, Philadelphia, PA 19104 USA, [Seidlitz, J.] Childrens Hosp Philadelphia, Dept Child & Adolescent Psychiat & Behav Sci, Philadelphia, PA 19104 USA, [Alexander-Bloch, A. F.] Childrens Hosp Philadelphia, Dept Child & Adolescent Psychiat & Behav Sci, Philadelphia, PA 19104 USA, [Seidlitz, J.] Childrens Hosp Philadelphia & Penn Med, Lifespan Brain Inst, Philadelphia, PA USA, [Chertavian, C.] Childrens Hosp Philadelphia & Penn Med, Lifespan Brain Inst, Philadelphia, PA USA, [Gur, R. E.] Childrens Hosp Philadelphia & Penn Med, Lifespan Brain Inst, Philadelphia, PA USA, [Gur, R. C.] Childrens Hosp Philadelphia & Penn Med, Lifespan Brain Inst, Philadelphia, PA USA, [Alexander-Bloch, A. F.] Childrens Hosp Philadelphia & Penn Med, Lifespan Brain Inst, Philadelphia, PA USA, [White, S. R.] Univ Cambridge, Dept Psychiat, Cambridge, England, [Goodyer, I. M.] Univ Cambridge, Dept Psychiat, Cambridge, England, [Henson, R. N.] Univ Cambridge, Dept Psychiat, Cambridge, England, [Jones, P. B.] Univ Cambridge, Dept Psychiat, Cambridge, England, [Kitzbichler, M. G.] Univ Cambridge, Dept Psychiat, Cambridge, England, [Medic, N.] Univ Cambridge, Dept Psychiat, Cambridge, England, [Morgan, S. E.] Univ Cambridge, Dept Psychiat, Cambridge, England, [Romero-Garcia, R.] Univ Cambridge, Dept Psychiat, Cambridge, England, [Ronan, L.] Univ Cambridge, Dept Psychiat, Cambridge, England, [Suckling, J.] Univ Cambridge, Dept Psychiat, Cambridge, England, [Vertes, P. E.] Univ Cambridge, Dept Psychiat, Cambridge, England, [Warrier, V.] Univ Cambridge, Dept Psychiat, Cambridge, England, [Westwater, M. L.] Univ Cambridge, Dept Psychiat, Cambridge, England, [Ziauddeen, H.] Univ Cambridge, Dept Psychiat, Cambridge, England, [Bullmore, E. T.] Univ Cambridge, Dept Psychiat, Cambridge, England, [White, S. R.] Univ Cambridge, MRC Biostat Unit, Cambridge, England, [Vogel, J. W.] Univ Penn, Lifespan Informat & Neuroimaging Ctr, Philadelphia, PA 19104 USA, [Satterthwaite, T. D.] Univ Penn, Lifespan Informat & Neuroimaging Ctr, Philadelphia, PA 19104 USA, [Anderson, K. M.] Yale Univ, Dept Psychol, New Haven, CT USA, [Ellis, C. T.] Yale Univ, Dept Psychol, New Haven, CT USA, [Turk-Browne, N. B.] Yale Univ, Dept Psychol, New Haven, CT USA, [Adamson, C.] Murdoch Childrens Res Inst, Dev Imaging, Melbourne, Vic, Australia, [Ball, G.] Murdoch Childrens Res Inst, Dev Imaging, Melbourne, Vic, Australia, [Beare, R.] Murdoch Childrens Res Inst, Dev Imaging, Melbourne, Vic, Australia, [Jackowski, A. P.] Murdoch Childrens Res Inst, Dev Imaging, Melbourne, Vic, Australia, [Adamson, C.] Monash Univ, Dept Med, Melbourne, Vic, Australia, [Beare, R.] Monash Univ, Dept Med, Melbourne, Vic, Australia, [Adler, S.] UCL Great Ormond St Inst Child Hlth, London, England, [Alexopoulos, G. S.] Weill Cornell Med, Dept Psychiat, Weill Cornell Inst Geriatr Psychiat, New York, NY USA, [Anagnostou, E.] Univ Toronto, Dept Pediat, Toronto, ON, Canada, [Anagnostou, E.] Holland Bloorview Kids Rehabil Hosp, Toronto, ON, Canada, [Pierce, K.] Holland Bloorview Kids Rehabil Hosp, Toronto, ON, Canada, [Areces-Gonzalez, A.] Univ Elect Sci & Technol China, MOE Key Lab NeuroInformat, Clin Hosp, Chengdu Brain Sci Inst, Chengdu, Peoples R China, [Paz-Linares, D.] Univ Elect Sci & Technol China, MOE Key Lab NeuroInformat, Clin Hosp, Chengdu Brain Sci Inst, Chengdu, Peoples R China, [Areces-Gonzalez, A.] Univ Pinar del Rio Hermanos Saiz Montes de Oca, Pinar Del Rio, Cuba, [Astle, D. E.] Univ Cambridge, MRC Cognit & Brain Sci Unit, Cambridge, England, [Henson, R. N.] Univ Cambridge, MRC Cognit & Brain Sci Unit, Cambridge, England, [Whalley, H. C.] Univ Cambridge, MRC Cognit & Brain Sci Unit, Cambridge, England, [Auyeung, B.] Univ Edinburgh, Sch Philosophy Psychol & Language Sci, Dept Psychol, Edinburgh, Midlothian, Scotland, [Pausova, Z.] Univ Edinburgh, Sch Philosophy Psychol & Language Sci, Dept Psychol, Edinburgh, Midlothian, Scotland, [Ayub, M.] Queens Univ, Dept Psychiat, Ctr Neurosci Studies, Kingston, ON, Canada, [Ayub, M.] UCL, Mental Hlth Neurosci Res Dept, Div Psychiat, London, England, [Bae, J.] Seoul Natl Univ, Bundang Hosp, Dept Neuropsychiat, Seongnam, South Korea, [Ball, G.] Univ Melbourne, Dept Paediat, Melbourne, Vic, Australia, [Baron-Cohen, S.] Cambridgeshire & Peterborough NHS Fdn Trust, Cambridge Lifetime Asperger Syndrome Serv CLASS, Cambridge, England, [Benegal, V.] Natl Inst Mental Hlth & Neurosci NIMHANS, Ctr Addict Med, Bengaluru, India, [Beyer, F.] Max Planck Inst Human Cognit & Brain Sci, Dept Neurol, Leipzig, Germany, [Villringer, A.] Max Planck Inst Human Cognit & Brain Sci, Dept Neurol, Leipzig, Germany, [Witte, A. V.] Max Planck Inst Human Cognit & Brain Sci, Dept Neurol, Leipzig, Germany, [Blangero, J.] Univ Texas Rio Grande Valley, South Texas Diabet & Obes Inst, Dept Human Genet, Edinburg, TX USA, [Blesa Cabez, M.] Univ Edinburgh, MRC Ctr Reprod Hlth, Edinburgh, Midlothian, Scotland, [Boardman, J. P.] Univ Edinburgh, MRC Ctr Reprod Hlth, Edinburgh, Midlothian, Scotland, [Sullivan, G.] Univ Edinburgh, MRC Ctr Reprod Hlth, Edinburgh, Midlothian, Scotland, [Borzage, M.] Univ Southern Calif, Childrens Hosp Los Angeles, Keck Sch Med, Fetal & Neonatal Inst,Div Neonatol,Dept Pediat, Los Angeles, CA 90007 USA, [Bosch-Bayard, J. F.] Montreal Neurol Inst, Ludmer Ctr Neuroinformat & Mental Hlth, McGill Ctr Integrat Neurosci, Montreal, PQ, Canada, [Bosch-Bayard, J. F.] McGill Univ, Montreal, PQ, Canada, [Chakravarty, M. M.] McGill Univ, Montreal, PQ, Canada, [Bourke, N.] Imperial Coll London, Dept Brain Sci, London, England, [Sharp, D.] Imperial Coll London, Dept Brain Sci, London, England, [Alexander-Bloch, A. F.] Imperial Coll London, Dept Brain Sci, London, England, [Bourke, N.] Dementia Res Inst, Care Res & Technol Ctr, London, England, [Calhoun, V. D.] Georgia State Univ, Triinst Ctr Translat Res Neuroimaging & Data Sci, Georgia Inst Technol, Atlanta, GA 30303 USA, [Calhoun, V. D.] Emory Univ, Atlanta, GA 30322 USA, [Chakravarty, M. M.] Douglas Mental Hlth Univ Inst, Cerebral Imaging Ctr, Comp Brain Anat CoBrA Lab, Montreal, PQ, Canada, [Chen, C.] Univ Penn, Penn Stat Imaging & Visualizat Ctr, Dept Biostat Epidemiol & Informat, Perelman Sch Med, Philadelphia, PA 19104 USA, [Shinohara, R. T.] Univ Penn, Penn Stat Imaging & Visualizat Ctr, Dept Biostat Epidemiol & Informat, Perelman Sch Med, Philadelphia, PA 19104 USA, [Chetelat, G.] Normandie Univ, PhIND Physiopathol & Imaging Neurol Disorders, Inst Blood & Brain Caen Normandie, UNICAEN,INSERM,U1237, Caen, France, [Delarue, M.] Normandie Univ, PhIND Physiopathol & Imaging Neurol Disorders, Inst Blood & Brain Caen Normandie, UNICAEN,INSERM,U1237, Caen, France, [Landeau, B.] Normandie Univ, PhIND Physiopathol & Imaging Neurol Disorders, Inst Blood & Brain Caen Normandie, UNICAEN,INSERM,U1237, Caen, France, [Paly, L.] Normandie Univ, PhIND Physiopathol & Imaging Neurol Disorders, Inst Blood & Brain Caen Normandie, UNICAEN,INSERM,U1237, Caen, France, [Chong, Y. S.] Agcy Sci Technol & Res, Singapore Inst Clin Sci, Singapore, Singapore, [Chong, Y. S.] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Obstet & Gynaecol, Singapore, Singapore, [Cole, J. H.] UCL, Ctr Med Image Comp CMIC, London, England, [Cole, J. H.] UCL, Dementia Res Ctr DRC, London, England, [Corvin, A.] Trinity Coll Dublin, Dept Psychiat, Dublin, Ireland, [Costantino, M.] Douglas Mental Hlth Univ Inst, Cerebral Imaging Ctr, Verdun, PQ, Canada, [Costantino, M.] McGill Univ, Undergrad Program Neurosci, Montreal, PQ, Canada, [Courchesne, E.] Univ Calif San Diego, Dept Neurosci, San Diego, CA 92103 USA, [Courchesne, E.] Univ Calif San Diego, Autism Ctr Excellence, San Diego, CA 92103 USA, [Crivello, F.] Univ Bordeaux, Inst Neurodegenerat Disorders, CNRS UMR5293, CEA, Bordeaux, France, [Mazoyer, B.] Univ Bordeaux, Inst Neurodegenerat Disorders, CNRS UMR5293, CEA, Bordeaux, France, [Cropley, V. L.] Univ Melbourne, Melbourne Neuropsychiat Ctr, Melbourne, Vic, Australia, [Di Biase, M. A.] Univ Melbourne, Melbourne Neuropsychiat Ctr, Melbourne, Vic, Australia, [Lv, J.] Univ Melbourne, Melbourne Neuropsychiat Ctr, Melbourne, Vic, Australia, [Zalesky, A.] Univ Melbourne, Melbourne Neuropsychiat Ctr, Melbourne, Vic, Australia, [Hammill, C. F.] Hosp Sick Children, Toronto, ON, Canada, [Schachar, R. J.] Hosp Sick Children, Toronto, ON, Canada, [Crossley, N.] Pontificia Univ Catolica Chile, Sch Med, Dept Psychiat, Santiago, Chile, [Crossley, N.] Kings Coll London, Dept Psychosis Studies, Inst Psychiat Psychol & Neurosci, London, England, [McGuire, P.] Kings Coll London, Dept Psychosis Studies, Inst Psychiat Psychol & Neurosci, London, England, [Crossley, N.] Inst Milenio Intelligent Healthcare Engn, Santiago, Chile, [Delorme, R.] Robert Debre Univ Hosp, AP HP, Child & Adolescent Psychiat Dept, Paris, France, [Delorme, R.] Inst Pasteur, Human Genet & Cognit Funct, Paris, France, [Desrivieres, S.] Kings Coll London, Inst Psychiat Psychol & Neurosci, Social Genet & Dev Psychiat Ctr, London, England, [Devenyi, G. A.] Douglas Mental Hlth Univ Inst, McGill Dept Psychiat, Cerebral Imaging Ctr, Montreal, PQ, Canada, [Devenyi, G. A.] McGill Univ, Dept Psychiat, Montreal, PQ, Canada, [Di Biase, M. A.] Harvard Med Sch, Brigham & Womens Hosp, Dept Psychiat, Boston, MA 02115 USA, [Dolan, R.] UCL, Max Planck UCL Ctr Computat Psychiat & Ageing Res, London, England, [Dolan, R.] Wellcome Ctr Human Neuroimaging, London, England, [Wagstyl, K.] Wellcome Ctr Human Neuroimaging, London, England, [Donald, K. A.] Red Cross War Mem Childrens Hosp, Dept Paediat & Child Hlth, Div Dev Paediat, Cape Town, South Africa, [Donald, K. A.] Univ Cape Town, Neurosci Inst, Cape Town, South Africa, [Groenewold, N. A.] Univ Cape Town, Neurosci Inst, Cape Town, South Africa, [Donohoe, G.] Natl Univ Ireland Galway, Sch Psychol, Ctr Neuroimaging Cognit & Genom NICOG, Galway, Ireland, [Dunlop, K.] Weill Cornell Med, Dept Psychiat, Weil Family Brain & Mind Res Inst, New York, NY USA, [Lynch, C.] Weill Cornell Med, Dept Psychiat, Weil Family Brain & Mind Res Inst, New York, NY USA, [Edwards, A. D.] Kings Coll London, Ctr Dev Brain, London, England, [Edwards, A. D.] Evelina London Childrens Hosp, London, England, [Edwards, A. D.] MRC Ctr Neurodev Disorders, London, England, [Elison, J. T.] Univ Minnesota, Mason Inst Dev Brain, Dept Pediat, Inst Child Dev, Minneapolis, MN USA, [Fair, D. A.] Univ Minnesota, Mason Inst Dev Brain, Dept Pediat, Inst Child Dev, Minneapolis, MN USA, [Feczko, E.] Univ Minnesota, Mason Inst Dev Brain, Dept Pediat, Inst Child Dev, Minneapolis, MN USA, [Ellis, C. T.] Haskins Labs Inc, New Haven, CT USA, [Elman, J. A.] Univ Calif San Diego, Dept Psychiat, Ctr Behav Genet Aging, La Jolla, CA 92093 USA, [Franz, C. E.] Univ Calif San Diego, Dept Psychiat, Ctr Behav Genet Aging, La Jolla, CA 92093 USA, [Kremen, W. S.] Univ Calif San Diego, Dept Psychiat, Ctr Behav Genet Aging, La Jolla, CA 92093 USA, [Eyler, L.] VA San Diego Healthcare, Desert Pacific Mental Illness Res Educ & Clin Ctr, San Diego, CA USA, [Eyler, L.] Univ Calif San Diego, Dept Psychiat, Los Angeles, CA USA, [Fletcher, P. C.] Univ Cambridge, Dept Psychiat, Cambridge Biomed Campus, Cambridge, England, [Fletcher, P. C.] Wellcome Trust MRC Inst Metab Sci, Cambridge Biomed Campus, Cambridge, England, [Fletcher, P. C.] Cambridgeshire & Peterborough NHS Fdn Trust, Cambridge, England, [Jones, P. B.] Cambridgeshire & Peterborough NHS Fdn Trust, Cambridge, England, [Suckling, J.] Cambridgeshire & Peterborough NHS Fdn Trust, Cambridge, England, [Ziauddeen, H.] Cambridgeshire & Peterborough NHS Fdn Trust, Cambridge, England, [Fonagy, P.] UCL, Dept Clin Educ & Hlth Psychol, London, England, [Fonagy, P.] Anna Freud Natl Ctr Children & Families, London, England, [Galan-Garcia, L.] Cuban Ctr Neurosci, Havana, Cuba, [Valdes-Sosa, M. J.] Cuban Ctr Neurosci, Havana, Cuba, [Gholipour, A.] Boston Childrens Hosp, Computat Radiol Lab, Boston, MA USA, [Warfield, S. K.] Boston Childrens Hosp, Computat Radiol Lab, Boston, MA USA, [Giedd, J.] Univ Calif San Diego, Dept Child & Adolescent Psychiat, San Diego, CA 92103 USA, [Giedd, J.] Univ Calif San Diego, Dept Psychiat, San Diego, CA 92103 USA, [Gilmore, J. H.] Univ N Carolina, Dept Psychiat, Chapel Hill, NC 27515 USA, [Glahn, D. C.] Boston Childrens Hosp, Dept Psychiat, Boston, MA USA, [Im, K.] Boston Childrens Hosp, Dept Psychiat, Boston, MA USA, [Mathias, S. R.] Boston Childrens Hosp, Dept Psychiat, Boston, MA USA, [Rodrigue, A.] Boston Childrens Hosp, Dept Psychiat, Boston, MA USA, [Glahn, D. C.] Harvard Med Sch, Boston, MA 02115 USA, [Im, K.] Harvard Med Sch, Boston, MA 02115 USA, [Johnson, K. A.] Harvard Med Sch, Boston, MA 02115 USA, [Mathias, S. R.] Harvard Med Sch, Boston, MA 02115 USA, [Rodrigue, A.] Harvard Med Sch, Boston, MA 02115 USA, [Schultz, A. P.] Harvard Med Sch, Boston, MA 02115 USA, [Sperling, R. A.] Harvard Med Sch, Boston, MA 02115 USA, [Grant, P. E.] Harvard Med Sch, Fetal Neonatal Neuroimaging & Dev Sci Ctr, Boston Childrens Hosp, Div Newborn Med & Neuroradiol, Boston, MA 02115 USA, [Groenewold, N. A.] Univ Cape Town, SA MRC Unit Child & Adolescent Hlth, Red Cross War Mem Childrens Hosp, Dept Paediat & Child Hlth, Cape Town, South Africa, [Zar, H. J.] Univ Cape Town, SA MRC Unit Child & Adolescent Hlth, Red Cross War Mem Childrens Hosp, Dept Paediat & Child Hlth, Cape Town, South Africa, [Gunning, F. M.] Weill Cornell Med, Dept Psychiat, Weill Cornell Inst Geriatr Psychiat, New York, NY USA, [Victoria, L. W.] Weill Cornell Med, Dept Psychiat, Weill Cornell Inst Geriatr Psychiat, New York, NY USA, [Hammill, C. F.] Mouse Imaging Ctr, Toronto, ON, Canada, [Hansson, O.] Lund Univ, Dept Clin Sci Malmo, Clin Memory Res Unit, Malmo, Sweden, [Hansson, O.] Skane Univ Hosp, Memory Clin, Malmo, Sweden, [Hedden, T.] Icahn Sch Med Mt Sinai, Dept Neurol, New York, NY 10029 USA, [Hedden, T.] Harvard Med Sch, Massachusetts Gen Hosp, Dept Radiol, Athinoula Martinos Ctr Biomed Imaging, Boston, MA 02115 USA, [Heinz, A.] Charite Univ Med Berlin, Charite Campus Mitte, Berlin, Germany, [Heinz, A.] Free Univ Berlin, Charite Campus Mitte, Berlin, Germany, [Heinz, A.] Humboldt Univ, Dept Psychiat & Psychotherapy, Charite Campus Mitte, Berlin, Germany, [Heuer, K.] Max Planck Inst Human Cognit & Brain Sci, Dept Neuropsychol, Leipzig, Germany, [Heuer, K.] Univ Paris, Paris, France, [Toro, R.] Univ Paris, Paris, France, [Hoare, J.] Univ Cape Town, Dept Psychiat, Cape Town, South Africa, [Holla, B.] NIMHANS, Dept Integrat Med, Bengaluru, India, [Holla, B.] NIMHANS, Dept Psychiat, Accelerator Program Discovery Brain Disorders Usi, Bengaluru, India, [Holmes, A. J.] Yale Univ, Dept Psychol, New Haven, CT USA, [Villeneuve, S.] Yale Univ, Dept Psychol, New Haven, CT USA, [Holmes, A. J.] Yale Univ, Dept Psychiat, New Haven, CT 06520 USA, [Villeneuve, S.] Yale Univ, Dept Psychiat, New Haven, CT 06520 USA, [Huang, H.] Childrens Hosp Philadelphia, Radiol Res, Philadelphia, PA 19104 USA, [Ouyang, M.] Childrens Hosp Philadelphia, Radiol Res, Philadelphia, PA 19104 USA, [Huang, H.] Univ Penn, Dept Radiol, Perelman Sch Med, Philadelphia, PA 19104 USA, [Ipser, J.] Univ Cape Town, Dept Psychiat & Mental Hlth, Clin Neurosci Inst, Cape Town, South Africa, [Jack, C. R., Jr.] Mayo Clin, Dept Radiol, Rochester, MN USA, [Jones, D. T.] Mayo Clin, Dept Radiol, Rochester, MN USA, Univ Fed Sao Paulo, Dept Psychiat, Sao Paulo, Brazil, [Jackowski, A. P.] Natl Inst Dev Psychiat, Beijing, Peoples R China, [Jia, T.] Fudan Univ, Inst Sci & Technol Brain Inspired Intelligence, Shanghai, Peoples R China, [Jia, T.] Fudan Univ, Minist Educ, Key Lab Computat Neurosci & Brain Inspired Intell, Shanghai, Peoples R China, [Jia, T.] Kings Coll London, Inst Psychiat Psychol & Neurosci, Ctr Populat Neurosci & Precis Med PONS, SGDP Ctr, London, England, [Johnson, K. A.] Massachusetts Gen Hosp, Dept Neurol, Harvard Aging Brain Study, Boston, MA 02114 USA, [Schultz, A. P.] Massachusetts Gen Hosp, Dept Neurol, Harvard Aging Brain Study, Boston, MA 02114 USA, [Sperling, R. A.] Massachusetts Gen Hosp, Dept Neurol, Harvard Aging Brain Study, Boston, MA 02114 USA, [Johnson, K. A.] Brigham & Womens Hosp, Dept Neurol, Ctr Alzheimer Res & Treatment, 75 Francis St, Boston, MA 02115 USA, [Sperling, R. A.] Brigham & Womens Hosp, Dept Neurol, Ctr Alzheimer Res & Treatment, 75 Francis St, Boston, MA 02115 USA, [Johnson, K. A.] Massachusetts Gen Hosp, Dept Radiol, Boston, MA USA, [Jones, D. T.] Mayo Clin, Dept Neurol, Rochester, MN USA, [3R-BRAIN] Mayo Clin, Dept Neurol, Rochester, MN USA, [Kahn, R. S.] Icahn Sch Med Mt Sinai, Dept Psychiat, New York, NY 10029 USA, [Karlsson, H.] Univ Turku, Dept Psychiat, Dept Clin Med, Turku, Finland, [Karlsson, L.] Univ Turku, Dept Psychiat, Dept Clin Med, Turku, Finland, [Tuulari, J. J.] Univ Turku, Dept Psychiat, Dept Clin Med, Turku, Finland, [Karlsson, H.] Univ Turku, FinnBrain Birth Cohort Study, Turku Brain & Mind Ctr, Turku, Finland, [Karlsson, L.] Univ Turku, FinnBrain Birth Cohort Study, Turku Brain & Mind Ctr, Turku, Finland, [Tuulari, J. J.] Univ Turku, FinnBrain Birth Cohort Study, Turku Brain & Mind Ctr, Turku, Finland, [Karlsson, H.] Turku Univ Hosp, Turku, Finland, [Karlsson, L.] Turku Univ Hosp, Turku, Finland, [Tuulari, J. J.] Turku Univ Hosp, Turku, Finland, [Karlsson, H.] Turku Univ Hosp, Ctr Populat Hlth Res, Turku, Finland, [Karlsson, L.] Turku Univ Hosp, Ctr Populat Hlth Res, Turku, Finland, [Karlsson, H.] Univ Turku, Turku, Finland, [Karlsson, L.] Univ Turku, Turku, Finland, [Kawashima, R.] Tohoku Univ, Inst Dev Aging & Canc, Aoba Ku, Sendai, Miyagi, Japan, [Taki, Y.] Tohoku Univ, Inst Dev Aging & Canc, Aoba Ku, Sendai, Miyagi, Japan, [Thyreau, B.] Tohoku Univ, Inst Dev Aging & Canc, Aoba Ku, Sendai, Miyagi, Japan, [Kelley, E. A.] Queens Univ, Ctr Neurosci Studies, Dept Psychol, Kingston, ON, Canada, [Kelley, E. A.] Queens Univ, Ctr Neurosci Studies, Dept Psychiat, Kingston, ON, Canada, [Kern, S.] Univ Gothenburg, Neuropsychiat Epidemiol Unit, Dept Psychiat & Neurochem,Sahlgrenska Acad, Ctr Ageing & Hlth AGECAP,Inst Neurosci & Physiol, Gothenburg, Sweden, [Skoog, I.] Univ Gothenburg, Neuropsychiat Epidemiol Unit, Dept Psychiat & Neurochem,Sahlgrenska Acad, Ctr Ageing & Hlth AGECAP,Inst Neurosci & Physiol, Gothenburg, Sweden, [Zettergren, A.] Univ Gothenburg, Neuropsychiat Epidemiol Unit, Dept Psychiat & Neurochem,Sahlgrenska Acad, Ctr Ageing & Hlth AGECAP,Inst Neurosci & Physiol, Gothenburg, Sweden, [Kern, S.] Sahlgrens Univ Hosp, Psychiat Cognit & Old Age Psychiat Clin, Reg Vastra Gotaland, Gothenburg, Sweden, [Skoog, I.] Sahlgrens Univ Hosp, Psychiat Cognit & Old Age Psychiat Clin, Reg Vastra Gotaland, Gothenburg, Sweden, [Kim, K. W.] Seoul Natl Univ, Dept Brain & Cognit Sci, Coll Nat Sci, Seoul, South Korea, [Kim, K. W.] Seoul Natl Univ, Bundang Hosp, Dept Neuropsychiat, Seongnam, South Korea, [Kim, K. W.] Seoul Natl Univ, Dept Psychiat, Coll Med, Seoul, South Korea, [Kim, K. W.] SNU MRC, Inst Human Behav Med, Seoul, South Korea, [Lalonde, F.] NIMH, Sect Dev Neurogenom, Human Genet Branch, Bethesda, MD 20892 USA, [Raznahan, A.] NIMH, Sect Dev Neurogenom, Human Genet Branch, Bethesda, MD 20892 USA, [Lee, S.] Seoul Natl Univ, Coll Nat Sci, Dept Brain & Cognit Sci, Seoul, South Korea, [Lerch, J.] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada, [Lerch, J.] Univ Oxford, Nuffield Dept Clin Neurosci, FMRIB, Wellcome Ctr Integrat Neuroimaging, Oxford, England, [Lewis, J. D.] McGill Univ, Montreal Neurol Inst, Montreal, PQ, Canada, [Li, J.] Univ Elect Sci & Technol China, Clin Hosp, Chengdu Brain Sci Inst, Chengdu, Peoples R China, [Liao, W.] Univ Elect Sci & Technol China, Clin Hosp, Chengdu Brain Sci Inst, Chengdu, Peoples R China, [Valdes-Sosa, P. A.] Univ Elect Sci & Technol China, Clin Hosp, Chengdu Brain Sci Inst, Chengdu, Peoples R China, [Liston, C.] Weill Cornell Med, Dept Psychiat, New York, NY USA, [Liston, C.] Weill Cornell Med, Brain & Mind Res Inst, New York, NY USA, [Lombardo, M. V.] Ist Italiano Tecnol, Ctr Neurosci & Cognit Syst UniTn, Lab Autism & Neurodev Disorders, Rovereto, Italy, [Lv, J.] Univ Sydney, Sch Biomed Engn, Sydney, NSW, Australia, [Lv, J.] Univ Sydney, Brain & Mind Ctr, Sydney, NSW, Australia, [Mallard, T. T.] Univ Texas Austin, Dept Psychol, Austin, TX 78712 USA, [Marcelis, M.] Maastricht Univ, Sch Mental Hlth & Neurosci, Dept Psychiat & Neuropsychol, EURON,Med Ctr, Maastricht, Netherlands, [Marcelis, M.] Inst Mental Hlth Care Eindhoven GGzE, Eindhoven, Netherlands, [Markello, R. D.] McGill Univ, Montreal Neurol Inst, McConnell Brain Imaging Ctr, Montreal, PQ, Canada, [Misic, B.] McGill Univ, Montreal Neurol Inst, McConnell Brain Imaging Ctr, Montreal, PQ, Canada, [Vasung, L.] McGill Univ, Montreal Neurol Inst, McConnell Brain Imaging Ctr, Montreal, PQ, Canada, [Mazoyer, B.] Douglas Mental Hlth Univ Inst, Ludmer Ctr Neuroinformat & Mental Hlth, Montreal, PQ, Canada, [Meaney, M. J.] Douglas Mental Hlth Univ Inst, Ludmer Ctr Neuroinformat & Mental Hlth, Montreal, PQ, Canada, [Meaney, M. J.] Singapore Inst Clin Sci, Singapore, Singapore, [Mechelli, A.] Bordeaux Univ Hosp, Bordeaux, France, [Morgan, S. E.] Univ Cambridge, Dept Comp Sci & Technol, Cambridge, England, [Morgan, S. E.] Alan Turing Inst, London, England, [Vertes, P. E.] Alan Turing Inst, London, England, [Mothersill, D.] Natl Coll Ireland, Sch Business, Dept Psychol, Dublin, Ireland, [Mothersill, D.] Natl Univ Ireland Galway, Sch Psychol, Galway, Ireland, [Mothersill, D.] Natl Univ Ireland Galway, Ctr Neuroimaging & Cognit Genom, Galway, Ireland, [Mothersill, D.] Trinity Coll Dublin, Dept Psychiat, Dublin, Ireland, [Nigg, J.] Oregon Hlth & Sci Univ, Dept Psychiat, Sch Med, Portland, OR 97201 USA, [Ong, M. Q. W.] Natl Univ Singapore, Yong Loo Lin Sch Med, Ctr Sleep & Cognit, Singapore, Singapore, [Qian, X.] Natl Univ Singapore, Yong Loo Lin Sch Med, Ctr Sleep & Cognit, Singapore, Singapore, [Zhou, J. H.] Natl Univ Singapore, Yong Loo Lin Sch Med, Ctr Sleep & Cognit, Singapore, Singapore, [Ortinau, C.] Washington Univ, Dept Pediat, St Louis, MO 63130 USA, [Ossenkoppele, R.] Vrije Univ Amsterdam, Alzheimer Ctr Amsterdam, Amsterdam UMC, Dept Neurol,Amsterdam Neurosci, Amsterdam, Netherlands, [Ossenkoppele, R.] Lund Univ, Clin Memory Res Unit, Lund, Sweden, [Palaniyappan, L.] Univ Western Ontario, Robarts Res Inst, London, ON, Canada, [Palaniyappan, L.] Univ Western Ontario, Brain & Mind Inst, London, ON, Canada, [Pan, P. M.] Fed Univ Sao Poalo UNIFESP, Dept Psychiat, Sao Poalo, Brazil, [Pan, P. M.] Natl Inst Dev Psychiat Children & Adolescents INP, Sao Poalo, Brazil, [Zugman, A.] Natl Inst Dev Psychiat Children & Adolescents INP, Sao Poalo, Brazil, [Pantelis, C.] Univ Melbourne, Dept Psychiat, Melbourne Neuropsychiat Ctr, Carlton, Vic, Australia, [Pantelis, C.] Melbourne Hlth, Carlton, Vic, Australia, [Pantelis, C.] Univ Melbourne, Melbourne Sch Engn, Parkville, Vic, Australia, [Pantelis, C.] Florey Inst Neurosci & Mental Hlth, Parkville, Vic, Australia, [Park, M. M.] Western Univ, Schulich Sch Med & Dent, Dept Psychiat, London, ON, Canada, [Rollins, C. K.] Univ Montreal, Dept Psychiat, Fac Med, Montreal, PQ, Canada, [Rollins, C. K.] Univ Montreal, CHU St Justine, Montreal, PQ, Canada, [Romero-Garcia, R.] Univ Toronto, Dept Psychiat, Toronto, ON, Canada, [Romero-Garcia, R.] Univ Toronto, Dept Psychol, Toronto, ON, Canada, [Rosenberg, M. D.] Univ Toronto, Dept Physiol, Toronto, ON, Canada, [Rosenberg, M. D.] Univ Toronto, Dept Nutr Sci, Toronto, ON, Canada, [Paz-Linares, D.] Cuban Neurosci Ctr, Havana, Cuba, [Pichet Binette, A.] McGill Univ, Fac Med, Dept Psychiat, Montreal, PQ, Canada, [Villeneuve, S.] McGill Univ, Fac Med, Dept Psychiat, Montreal, PQ, Canada, [Pichet Binette, A.] Douglas Mental Hlth Univ Inst, Montreal, PQ, Canada, [Villeneuve, S.] Douglas Mental Hlth Univ Inst, Montreal, PQ, Canada, [Qiu, J.] Southwest Univ, Sch Psychol, Chongqing, Peoples R China, [Qiu, A.] Natl Univ Singapore, N1 Inst Hlth, Dept Biomed Engn, Singapore, Singapore, [Rittman, T.] Univ Cambridge, Dept Clin Neurosci, Cambridge, England, [Tsvetanov, K. A.] Univ Cambridge, Dept Clin Neurosci, Cambridge, England, [Rollins, C. K.] Harvard Med Sch, Dept Neurol, Boston, MA 02115 USA, [Rollins, C. K.] Boston Childrens Hosp, Dept Neurol, Boston, MA USA, [Romero-Garcia, R.] Univ Seville, Dpto Fisiol Med & Biofis, Inst Biomed Sevilla IBiS HUVR CSIC, Seville, Spain, [Rosenberg, M. D.] Univ Chicago, Dept Psychol, 5848 S Univ Ave, Chicago, IL 60637 USA, [Rosenberg, M. D.] Univ Chicago, Inst Neurosci, Chicago, IL USA, [Rowitch, D. H.] Univ Cambridge, Dept Paediat, Cambridge, England, [Rowitch, D. H.] Univ Cambridge, Wellcome MRC Cambridge Stem Cell Inst, Cambridge, England, [Salum, G. A.] Univ Fed Rio Grande Sul UFRGS, Hosp Clin Porto Alegre, Dept Psychiat, Porto Alegre, RS, Brazil, [Salum, G. A.] Natl Inst Dev Psychiat INPD, Sao Paulo, Brazil, [Schaare, H. L.] Max Planck Inst Human Cognit & Brain Sci, Otto Hahn Grp Cognit Neurogenet, Leipzig, Germany, [Schaare, H. L.] Res Ctr Juelich, Inst Neurosci & Med INM 7 Brain & Behav, Julich, Germany, [Schultz, A. P.] Massachusetts Gen Hosp, Dept Radiol, Athinoula Martinos Ctr Biomed Imaging, Charlestown, MA USA, [Schumann, G.] Fudan Univ, Inst Sci & Technol Brain Inspired Intelligence, Ctr Populat Neurosci & Stratified Med PONS, Shanghai, Peoples R China, [Schumann, G.] Charite Campus Mitte, Dept Psychiat & Psychotherapy, Charite Mental Hlth, PONS Ctr, Berlin, Germany, [Scholl, M.] Univ Gothenburg, Wallenberg Ctr Mol & Translat Med, Gothenburg, Sweden, [Scholl, M.] Univ Gothenburg, Dept Psychiat & Neurochem, Gothenburg, Sweden, [Scholl, M.] UCL, Queens Sq Inst Neurol, Dementia Res Ctr, London, England, [Sharp, D.] UK Dementia Res Inst, Care Res & Technol Ctr, London, England, [Shinohara, R. T.] Univ Penn, Perelman Sch Med, Dept Radiol, Ctr Biomed Image Comp & Analyt, Philadelphia, PA 19104 USA, [Smyser, C. D.] Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA, [Smyser, C. D.] Washington Univ, Sch Med, Dept Pediat, St Louis, MO 63110 USA, [Smyser, C. D.] Washington Univ, Sch Med, Dept Radiol, St Louis, MO 63110 USA, [Stein, D. J.] Univ Cape Town, Dept Psychiat, SA MRC Unit Risk & Resilience Mental Disorders, Cape Town, South Africa, [Stein, D. J.] Univ Cape Town, Neurosci Inst, Cape Town, South Africa, [Stolicyn, A.] Univ Edinburgh, Ctr Clin Brain Sci, Div Psychiat, Edinburgh, Midlothian, Scotland, [Whalley, H. C.] Univ Edinburgh, Ctr Clin Brain Sci, Div Psychiat, Edinburgh, Midlothian, Scotland, [Toro, R.] Inst Pasteur, Dept Neurosci, Paris, France, [Traut, N.] Inst Pasteur, Dept Neurosci, Paris, France, [Traut, N.] Univ Paris 05, Ctr Res & Interdisciplinar CRI, Paris, France, [Tsvetanov, K. A.] Univ Cambridge, Dept Psychol, Cambridge, England, [Turk-Browne, N. B.] Yale Univ, Wu Tsai Inst, New Haven, CT USA, [Tuulari, J. J.] Univ Turku, Dept Clin Med, Turku, Finland, [Tuulari, J. J.] Univ Turku, Turku Coll Sci Med & Technol, Turku, Finland, [Tzourio, C.] Univ Bordeaux, Bordeaux Populat Hlth Res Ctr, CHU Bordeaux, U1219,INSERM, Bordeaux, France, [Vachon-Presseau, E.] McGill Univ, Fac Dent Med & Oral Hlth Sci, Montreal, PQ, Canada, [Valdes-Sosa, P. A.] McGill Univ, Alan Edwards Ctr Res Pain AECRP, Montreal, PQ, Canada, [Valk, S. L.] Forschungszentrum Julich, Inst Neurosci & Med 7, Julich, Germany, [Valk, S. L.] Max Planck Inst Human Cognit & Brain Sci, Leipzig, Germany, [van Amelsvoort, T.] Maastricht Univ, Dept Psychiat & Neurosychol, Maastricht, Netherlands, [Vandekar, S. N.] Vanderbilt Univ, Dept Biostat, 221 Kirkland Hall, Nashville, TN 37235 USA, [Villeneuve, S.] Vanderbilt Univ, Med Ctr, Dept Biostat, Nashville, TN USA, [Villringer, A.] Univ Leipzig, Clin Cognit Neurol, Med Ctr, Leipzig, Germany, [Witte, A. V.] Univ Leipzig, Clin Cognit Neurol, Med Ctr, Leipzig, Germany, [Zuo, X. N.] Univ Leipzig, Clin Cognit Neurol, Med Ctr, Leipzig, Germany, [Wang, Y. S.] Beijing Normal Univ, State Key Lab Cognit Neurosci & Learning, Beijing, Peoples R China, [Yang, N.] Beijing Normal Univ, State Key Lab Cognit Neurosci & Learning, Beijing, Peoples R China, [Yeo, B.] Beijing Normal Univ, State Key Lab Cognit Neurosci & Learning, Beijing, Peoples R China, [Zuo, X. N.] Beijing Normal Univ, State Key Lab Cognit Neurosci & Learning, Beijing, Peoples R China, [Wang, Y. S.] Beijing Normal Univ, IDG McGovern Inst Brain Res, Dev Populat Neuroscience Res Ctr, Beijing, Peoples R China, [Yang, N.] Beijing Normal Univ, IDG McGovern Inst Brain Res, Dev Populat Neuroscience Res Ctr, Beijing, Peoples R China, [Zuo, X. N.] Beijing Normal Univ, IDG McGovern Inst Brain Res, Dev Populat Neuroscience Res Ctr, Beijing, Peoples R China, [Wang, Y. S.] Natl Basic Sci Data Ctr, Beijing, Peoples R China, [Yang, N.] Natl Basic Sci Data Ctr, Beijing, Peoples R China, [Zuo, X. N.] Natl Basic Sci Data Ctr, Beijing, Peoples R China, [Wang, Y. S.] Chinese Acad Sci, Res Ctr Lifespan Dev Brain & Mind, Inst Psychol, Beijing, Peoples R China, [Yang, N.] Chinese Acad Sci, Res Ctr Lifespan Dev Brain & Mind, Inst Psychol, Beijing, Peoples R China, [Westman, E.] Karolinska Inst, Ctr Alzheimer Res, Dept Neurobiol Care Sci & Soc, Div Clin Geriatr, Stockholm, Sweden, [Witte, A. V.] Univ Leipzig, CRC 1052 Obes Mech, Fac Med, Leipzig, Germany, [Zhou, J. H.] Natl Univ Singapore, Dept Elect & Comp Engn, Singapore, Singapore, [Yeo, B.] Natl Univ Singapore, Yong Loo Lin Sch Med, Ctr Sleep & Cognit, Singapore, Singapore, [Yeo, B.] Natl Univ Singapore, Yong Loo Lin Sch Med, Ctr Translat MR Res, Singapore, Singapore, [Yeo, B.] Natl Univ Singapore, N1 Inst Hlth, Singapore, Singapore, [Yeo, B.] Natl Univ Singapore, Inst Digital Med, Singapore, Singapore, [Yun, H.] Natl Univ Singapore, Integrat Sci & Engn Programme ISEP, Singapore, Singapore, [Zar, H. J.] Univ Melbourne, Dept Biomed Engn, Melbourne, Vic, Australia, [Zhou, J. H.] Natl Univ Singapore, Yong Loo Lin Sch Med, Ctr Translat Magnet Resonance Res, Singapore, Singapore, [Ziauddeen, H.] Univ Cambridge, Wellcome Trust MRC Inst Metab Sci, Cambridge, England, [Zugman, A.] NIMH, NIH, Bethesda, MD 20892 USA, [Zugman, A.] Escola Paulista Med, Dept Psychiat, Sao Paulo, Brazil, [Zuo, X. N.] Nanning Normal Univ, Sch Educ Sci, Key Lab Brain & Educ, Nanning, Peoples R China, British Academy Postdoctoral fellowship, NIMH, UKRI Medical Research Council, NIHR Cambridge Biomedical Research Centre, NIHR Senior Investigator award, MRC research infrastructure award, Commonwealth Scientific and Industrial Research Organisation (CSIRO), and Ontario Brain Institute
- Subjects
631/378/2649 ,OpenPain Project ,KNE96 ,Growth ,Psychiatric-disorders ,DISEASE ,3R-BRAIN ,Brain charts ,MRI Brain ,OASIS-3 ,Disease ,CCNP ,631/378/2571 ,UMN BCP ,Multidisciplinary ,medicine.diagnostic_test ,PSYCHIATRIC-DISORDERS ,article ,Brain ,Human brain ,ASSOCIATION ,Magnetic Resonance Imaging ,Harvard Aging Brain Study ,The Mayo Clinic Study of Aging, NSPN ,medicine.anatomical_structure ,GROWTH ,[SDV.NEU]Life Sciences [q-bio]/Neurons and Cognition [q-bio.NC] ,ddc:500 ,BURDEN ,WHITE-MATTER ,FinnBrain, Harvard Aging Brain Study ,Organization ,Mri ,MRI ,medicine.medical_specialty ,Concurrent validity ,MODELS ,Cam-CAN ,Longevity ,CALM Team ,POND ,Neuroimaging ,Burden ,ORGANIZATION ,AIBL ,The PREVENT-AD Research Group, VETSA ,Cortical thickness ,Association ,Physical medicine and rehabilitation ,FinnBrain ,IMAGEN, KNE96 ,White-matter ,medicine ,Humans ,ASRB ,631/378/1689 ,COBRE ,business.industry ,631/378/2611 ,Brain morphometry ,Neurosciences ,Alzheimer’s Disease Repository Without Borders Investigators ,Magnetic resonance imaging ,Alzheimer’s Disease Neuroimaging Initiative ,Anthropometry ,Body Height ,Brain growth ,Birth ,59/57 ,Normative ,IMAGEN ,ENIGMA Developmental Brain Age working group ,NSPN ,business ,CCNP, 3R-BRAIN ,CORTICAL THICKNESS ,Developing Human Connectome Project, ENIGMA Developmental Brain Age working group ,The PREVENT-AD Research Group, VETSA, Bullmore, E.T - Abstract
Over the past few decades, neuroimaging has become a ubiquitous tool in basic research and clinical studies of the human brain. However, no reference standards currently exist to quantify individual differences in neuroimaging metrics over time, in contrast to growth charts for anthropometric traits such as height and weight1. Here we assemble an interactive open resource to benchmark brain morphology derived from any current or future sample of MRI data ( http://www.brainchart.io/ ). With the goal of basing these reference charts on the largest and most inclusive dataset available, acknowledging limitations due to known biases of MRI studies relative to the diversity of the global population, we aggregated 123,984 MRI scans, across more than 100 primary studies, from 101,457 human participants between 115 days post-conception to 100 years of age. MRI metrics were quantified by centile scores, relative to non-linear trajectories2 of brain structural changes, and rates of change, over the lifespan. Brain charts identified previously unreported neurodevelopmental milestones3, showed high stability of individuals across longitudinal assessments, and demonstrated robustness to technical and methodological differences between primary studies. Centile scores showed increased heritability compared with non-centiled MRI phenotypes, and provided a standardized measure of atypical brain structure that revealed patterns of neuroanatomical variation across neurological and psychiatric disorders. In summary, brain charts are an essential step towards robust quantification of individual variation benchmarked to normative trajectories in multiple, commonly used neuroimaging phenotypes., R.A.I.B. was supported by a British Academy Postdoctoral fellowship and by the Autism Research Trust. J. Seidlitz was supported by NIMH T32MH019112-29 and K08MH120564. S.R.W. was funded by UKRI Medical Research Council MC_UU_00002/2 and was supported by the NIHR Cambridge Biomedical Research Centre (BRC-1215-20014). E.T.B. was supported by an NIHR Senior Investigator award and the Wellcome Trust collaborative award for the Neuroscience in Psychiatry Network. A.F.A.-B. was supported by NIMH K08MH120564. Data were curated and analysed using a computational facility funded by an MRC research infrastructure award (MR/M009041/1) to the School of Clinical Medicine, University of Cambridge and supported by the mental health theme of the NIHR Cambridge Biomedical Research Centre.
- Published
- 2022
- Full Text
- View/download PDF
18. Outcome of gastrointestinal surgery during COVID-19 lockdown in a tertiary care hospital, Nepal
- Author
-
Sanjay Paudel, Niraj Giri, Shantabir Manarjan, Upendra Bhandari, Surendra Shah, Shailendra Shah, Suyog Bhandari, Samir Shrestha, Erena Pradhan, Saroj Babu Pradhan, Samyukta Kc, and Jay N Shah
- Subjects
medicine.medical_specialty ,Surgical strategy ,Coronavirus disease 2019 (COVID-19) ,business.industry ,Protective gear ,Medicine ,Perioperative ,Tertiary care hospital ,business ,Hospital stay ,Surgery - Abstract
Introduction: Perioperative strategies have been changing due to the COVID-19 pandemic to prevent the risk of postoperative complications and transmission of infection. This study was aimed to assess the outcome of gastrointestinal surgery and the risk of transmission by implementing COVID-19 testing criteria and surgical strategy. Method: This was a retrospective descriptive study conducted at the department of surgery at Patan Hospital, Nepal, during COVID-19 lock-down from 24 march to 15 June 2020. All patients who underwent gastrointestinal (GI) surgery were included. High-risk patients (as defined by the Hospital Incident Command System, HICS) were tested for COVID-19 preoperatively. Surgery was performed in COVID operating room with full protective gear. Low-risk patients were not tested for COVID-19 preoperatively and performed surgery in non-COVID OR. Data from patient’s case-sheets were analyzed descriptively for age, gender, comorbidities, hospital stay, RT-PCR results, surgeries, and postoperative complications. Result: There were total 44 GI surgeries performed; 31(70.5%) were emergency, 5(11.3%) semi-emergency and 8(18.2%) oncology. There were 11(25%) patients tested for COVID-19 preoperatively and were negative. Nine HCWs tested for COVID-19 randomly were negative. Severe postoperative complications developed in 3 patients, with one mortality. Conclusion: Among GI surgeries, there was no increase in postoperative complications and transmission of COVID-19 to the patients or HCWs following the implementation of standard testing criteria and surgical strategy.
- Published
- 2020
- Full Text
- View/download PDF
19. Determining the optimal duration for premature ventricular contraction monitoring
- Author
-
Shreyans K. Patel, Rachel M. Clark, Kevin J. Ferrick, Brian Hsia, Andrew Krumerman, John D. Fisher, Luigi Di Biase, Jay N. Gross, and Nicolas Greige
- Subjects
Adult ,Male ,medicine.medical_specialty ,Time Factors ,Heart Ventricles ,030204 cardiovascular system & hematology ,Ventricular Function, Left ,Ventricular contraction ,03 medical and health sciences ,0302 clinical medicine ,Heart Rate ,Physiology (medical) ,Internal medicine ,Linear regression ,medicine ,Retrospective analysis ,Humans ,030212 general & internal medicine ,Aged ,Retrospective Studies ,Aged, 80 and over ,Ambulatory electrocardiogram ,business.industry ,Mean age ,Middle Aged ,Myocardial Contraction ,Ventricular Premature Complexes ,Ambulatory ECG ,Electrocardiography, Ambulatory ,Cardiology ,Female ,Cardiology and Cardiovascular Medicine ,business ,Follow-Up Studies - Abstract
Background Premature ventricular contractions (VPC) have hour-to-hour and day-to-day variation. High VPC burden correlates with cardiomyopathy. Objective To determine the optimal duration for ambulatory electrocardiogram monitoring for accurate assessment of VPC burden. Methods Our group performed a retrospective analysis on patch monitors used for any indication with overall VPC burden ≥5.0% between February 1, 2016, and February 1, 2020. We generated cumulative daily VPC averages for each day of wear and performed linear regression analysis between each cumulative daily average and overall burden. Patients were divided into groups based on low or high VPC frequency, and the analysis was repeated. Split-sample validation was used to internally validate the overall prediction model. Results A total of 116 patches representing 107 patients (mean age: 64.5; female: 48%) were analyzed. Mean overall VPC burden was 13.4% ± 7.5% (range: 5.0%–42.0%). Day 1 R2 was 60%, P Conclusion Mobile telemetry for a period of ∼7 days accurately reflects overall VPC burden. Measurement of VPC burden for only 24–48 hours may not accurately reflect total burden. Monitoring for 2 weeks or longer adds little additional VPC information.
- Published
- 2020
- Full Text
- View/download PDF
20. Reducing Dislocations of Antibiotic Hip Spacers via Hybrid Cement-screw Constrained Liner Fixation: A Case Series
- Author
-
Richard S. Yoon, Richard A Pizzo, Anthony Viola, Jay N. Patel, David M. Keller, and Frank A. Liporace
- Subjects
musculoskeletal diseases ,medicine.medical_specialty ,hip ,medicine.drug_class ,Prosthetic joint ,medicine.medical_treatment ,Antibiotics ,Hip prosthesis ,replacement ,Prosthesis ,Arthroplasty ,03 medical and health sciences ,Fixation (surgical) ,0302 clinical medicine ,medicine ,Effective treatment ,Orthopedics and Sports Medicine ,030212 general & internal medicine ,030222 orthopedics ,business.industry ,Acetabulum ,Surgery ,Polyethylene ,Prosthesis-related infections ,Original Article ,Complication ,business - Abstract
Purpose: Infection following total hip arthroplasty is a challenging and devastating complication. In two-stage revision arthroplasty, antibiotic spacers, although efficacious, can be associated with an unacceptable rate of mechanical complications (e.g., fracture, dislocation). This series describes 15 patients with infected total hip prostheses treated with hybrid cement-screw fixation constrained liner antibiotic spacers to enhance stability and minimize mechanical complications. Materials and Methods: All patients with an infected hip prosthesis undergoing two-stage revision arthroplasty at a single academic medical center were identified and screened for inclusion. Clinical and radiographic data including patient demographics and outcome measures were collected and retrospectively analyzed. Results: Two patients died of unrelated causes at an average of 6-week postoperatively. Infections in the remaining thirteen patients (100%) were successfully eradicated; all underwent uncomplicated revision arthroplasty at a mean duration of 99.5 days after the placement of the antibiotic spacer. No dislocations, fractures, or other mechanical failures of any spacer were observed in this series. Conclusion: The hybrid cement-screw fixation technique for constrained liner antibiotic spacers is a reliable and effective treatment method for eradicating prosthetic joint infections without mechanical complications.
- Published
- 2020
21. Circulating levels and prognostic value of soluble ST2 in heart failure are less influenced by age than N-terminal pro-B-type natriuretic peptide and high-sensitivity troponin T
- Author
-
Kui Tong Gerard Leong, Robert N. Doughty, Fazlur Jaufeerally, Giuseppe Vergaro, Lars Gullestad, Jay N. Cohn, Antoni Bayes-Genis, Hans-Peter Brunner-La Rocca, Michele Emdin, Lieng H. Ling, Ida Gustafsson, Michael Egstrup, Kai M. Eggers, Yasuchika Takeishi, Hanna K. Gaggin, Hean Yee Ong, Richard W. Troughton, A. Mark Richards, Thor Ueland, Inder S. Anand, James L. Januzzi, Roberto Latini, Rudolf A. de Boer, Pål Aukrust, Claudio Passino, Carolyn S.P. Lam, Alberto Aimo, Josep Lupón, Tze P. Ng, Greg D. Gamble, Kurt Huber, Poh Shuah Daniel Yeo, Cardiologie, MUMC+: MA Med Staf Spec Cardiologie (9), RS: Carim - H02 Cardiomyopathy, and Cardiovascular Centre (CVC)
- Subjects
Male ,medicine.medical_specialty ,RENAL-FUNCTION ,medicine.drug_class ,Renal function ,Value (computer science) ,BIOLOGY ,Heart failure ,030204 cardiovascular system & hematology ,Ventricular Function, Left ,Age ,Biomarkers ,Prognosis ,sST2 ,03 medical and health sciences ,0302 clinical medicine ,Troponin T ,Internal medicine ,Natriuretic Peptide, Brain ,medicine ,Natriuretic peptide ,Humans ,EPIDEMIOLOGY ,cardiovascular diseases ,Aged ,Aged, 80 and over ,business.industry ,VDP::Medisinske Fag: 700::Basale medisinske, odontologiske og veterinærmedisinske fag: 710 ,Middle Aged ,medicine.disease ,High Sensitivity Troponin T ,musculoskeletal system ,Peptide Fragments ,VDP::Medical disciplines: 700::Basic medical, dental and veterinary science disciplines: 710 ,Endocrinology ,Female ,SEX ,N terminal pro b type natriuretic peptide ,Cardiology and Cardiovascular Medicine ,business ,hormones, hormone substitutes, and hormone antagonists - Abstract
This is the peer reviewed version of the following article: Aimo, A., Januzzi, J.L., Vergaro, G., Richards, A.M., Lam, C.S.P., Latini, R. ... Emdin, M. (2020). Circulating levels and prognostic value of soluble ST2 in heart failure are less influenced by age than N-terminal pro-B-type natriuretic peptide and high-sensitivity troponin T, European Journal of Heart Failure, which has been published in final form at https://doi.org/10.1002/ejhf.1701. . This article may be used for non-commercial purposes in accordance with Wiley Terms and Conditions for Use of Self-Archived Versions. Aims - N‐terminal pro‐B‐type natriuretic peptide (NT‐proBNP), high‐sensitivity troponin T (hs‐TnT) and soluble suppression of tumorigenesis‐2 (sST2) predict outcome in chronic heart failure (HF). We assessed the influence of age on circulating levels and prognostic significance of these biomarkers. Methods and results - Individual data from 5301 patients with chronic HF and NT‐proBNP, hs‐TnT, and sST2 data were evaluated. Patients were stratified according to age: Conclusions - Soluble ST2 is less influenced by age than NT‐proBNP or hs‐TnT; all these biomarkers predict outcome regardless of age. The use of age‐ and outcome‐specific cut‐offs of NT‐proBNP, hs‐TnT and sST2 allows more accurate risk stratification than NT‐proBNP alone or the combination of NT‐proBNP and hs‐TnT.
- Published
- 2020
- Full Text
- View/download PDF
22. Phase I trial of TRC102 (methoxyamine HCl) in combination with temozolomide in patients with relapsed solid tumors and lymphomas
- Author
-
Kazusa Ishii, Robert S. Meehan, Peter W. Laird, Jay N. Lozier, Larry D. Anderson, Angie B. Dull, Richard Piekarz, Andrea Regier Voth, Toshinori Hinoue, Jerry M. Collins, Katherine V. Ferry-Galow, James H. Doroshow, Elad Sharon, Howard Streicher, Khanh T. Do, Shivaani Kummar, Geraldine O.Sullivan Coyne, Naoko Takebe, Robert J. Kinders, Deborah Wilsker, Larry Rubinstein, Alice P. Chen, Jennifer Zlott, Ralph E. Parchment, and Lamin Juwara
- Subjects
Oncology ,medicine.medical_specialty ,Temozolomide ,Side effect ,business.industry ,Colorectal cancer ,Context (language use) ,Base excision repair ,Neutropenia ,medicine.disease ,base excision repair ,molecular pharmacodynamics ,Internal medicine ,medicine ,DNA damage repair ,Ovarian cancer ,Adverse effect ,business ,MGMT ,medicine.drug ,Research Paper ,rational combination therapy - Abstract
Background TRC102 inhibits base excision repair by binding abasic sites and preventing AP endonuclease processing; it potentiates the activity of alkylating agents, including temozolomide, in murine models. In published xenograft studies, TRC102 enhanced the antitumor effect of temozolomide regardless of cell line genetic characteristics, e.g., O6-methylguanine DNA methyltransferase (MGMT), mismatch repair (MMR), or p53 status. Materials and methods We conducted a phase 1 trial of TRC102 with temozolomide given orally on days 1-5 of 28-day cycles in adult patients with refractory solid tumors that had progressed on standard therapy. Tumor induction of nuclear biomarkers of DNA damage response (DDR) γH2AX, pNBs1, and Rad51 was assessed in the context of MGMT and MMR protein expression for expansion cohort patients. Results Fifty-two patients were enrolled (37 escalation, 15 expansion) with 51 evaluable for response. The recommended phase 2 dose was 125 mg TRC102, 150 mg/m2 temozolomide QDx5. Common adverse events (grade 3/4) included anemia (19%), lymphopenia (12%), and neutropenia (10%). Four patients achieved partial responses (1 non-small cell lung cancer, 2 granulosa cell ovarian cancer, and 1 colon cancer) and 13 patients had a best response of stable disease. Retrospective analysis of 15 expansion cohort patients did not demonstrate a correlation between low tumor MGMT expression and patient response, but treatment induced nuclear Rad51 responses in 6 of 12 patients. Conclusions The combination of TRC 102 with temozolomide is active, with 4 of 51 patients experiencing a partial response and 13 of 51 experiencing stable disease, and the side effect profile is manageable.
- Published
- 2020
23. Gastrointestinal Bleeding in Mechanical Cardiac Support
- Author
-
Alexander P McNally, Nicholas L. Bandy, Jiangtao Luo, Colten A Yahn, and Jay N. Collins
- Subjects
Heart Failure ,Male ,Gastrointestinal bleeding ,medicine.medical_specialty ,business.industry ,Incidence ,medicine.medical_treatment ,General Medicine ,Middle Aged ,medicine.disease ,Cardiac support ,Risk Factors ,Ventricular assist device ,Heart failure ,Internal medicine ,medicine ,Cardiology ,Humans ,Female ,In patient ,Heart-Assist Devices ,Gastrointestinal Hemorrhage ,business ,Retrospective Studies - Abstract
Background Mechanical cardiac support (MCS) is a lifesaving therapy option in patients with heart failure and other medical disorders. However, there is an associated risk of gastrointestinal bleeding (GIB). The goal of this study was to determine GIB incidence and associated risk factors. Methods All patients at one institution from 2009 to 2018 under durable and nondurable support were retrospectively reviewed for GIB during their MCS period. Clinical records were evaluated for patient demographics, GIB characteristics, and interventions. Univariate and multivariate analyses were performed to compare patient groups. Results A total of 427 patients were reviewed, with 111 (25.9%) patients representing 218 episodes of GIB during our study period. The incidence rate from support initiation to GIB was 44.9% by 6 months and 60.6% in 12 months, occurring at a mean of 216.7 days. Higher rates of bleeding were found in patients with hypertension (82% vs 71.5%; P = .03) and diabetes mellitus (62.2% vs 38.3%; P < .0001), as well as pulmonary (48.7% vs 35.4%; P = .014), hepatic (21.6% vs 10.4%; P = .003), and renal disease (48.7% vs 37.3%; P = .037). Endoscopy revealed an upper GI source in 56% (n = 123) of bleeds. The most common etiology of bleeding included angiodysplasia/vascular malformation (35.7%). Therapeutic intervention was performed in 109 (50%) cases, with only 1 surgical intervention. Discussion Overall, GIB can be a significant adverse event in patients under mechanical cardiac support, so proper management of anticoagulation and early endoscopy evaluation remains of great importance.
- Published
- 2020
- Full Text
- View/download PDF
24. Necrotizing enterocolitis: clinical characteristics and outcome of a cohort of 106 cases at a children’s hospital in North China
- Author
-
Jiao Fu Yong, Si Xi Yao, Li Hui Rong, and Jay N Shah
- Subjects
medicine.medical_specialty ,Neonatal intensive care unit ,Obstetrics ,business.industry ,Incidence (epidemiology) ,Perforation (oil well) ,Breastfeeding ,medicine.disease ,digestive system diseases ,Low birth weight ,Necrotizing enterocolitis ,medicine ,Fetal distress ,medicine.symptom ,business ,Premature rupture of membranes - Abstract
Introduction: Necrotizing enterocolitis (NEC) in neonates, especially in the preterm, is a life-threatening condition. This study aims to analyze the clinical profile of NEC to get an insight for better understanding and management. Method: This was a retrospective analysis of neonatal NEC during the six-year period from 2014 to 2019. The prevalence and time for the development of NEC, clinical profile (term and preterm, low birth weight, gender, breast and formula feeding, abdominal distension, vomiting, hematochezia, apnea, fever, altered mental status, blood transfusion, breast or formula-fed, intestinal perforation, Bell’s stage and time for the development of NEC) and maternal factors (gestational hypertension, diabetes, premature rupture of membranes PROM, intrauterine fetal distress, placenta previa) were analyzed. Features in preterm and term neonates were compared. Ethical approval was obtained. Result: There were 106 NEC (0.87% of 12,184 neonatal admissions), 62 (58.49%) male, 90 (84.91%) preterm, and 85 (80.19%) LBW. Overall, 88 (83.02%) were Bell’s stage II, and severe stage III was seen in eight (19.04%) out of 42 babies with formula feeding as compared to one (1.56%) out of 64 in breastfeeding. The median time for the development of NEC was 6 days of life. The yearly prevalence of NEC per thousand neonates admitted during 6-years increased from 2.90 in 2014 to 12.06 in 2019. Overall mortality was 14 (13.20%). Conclusion: The yearly incidence of NEC increased with a higher incidence in preterm, in low birth weight and formula-fed neonates.
- Published
- 2020
- Full Text
- View/download PDF
25. Providing Patient Mobilization With a Mobility Technician Improves Staff Efficiency and Constrains Cost in Primary Total Hip Arthroplasty
- Author
-
Roberta S. D’Achille, Christopher Mazzei, Jay N. Patel, John W. Yurek, James C. Wittig, and Eileen Poletick
- Subjects
Hip surgery ,030222 orthopedics ,medicine.medical_specialty ,Mobilization ,business.industry ,Arthroplasty, Replacement, Hip ,Technician ,medicine.medical_treatment ,Bundled payments ,Discharge disposition ,Length of Stay ,Hip resurfacing ,Patient Discharge ,03 medical and health sciences ,0302 clinical medicine ,Gait training ,Costs and Cost Analysis ,Physical therapy ,Humans ,Medicine ,Orthopedics and Sports Medicine ,Arthroplasty, Replacement, Knee ,business ,Retrospective Studies ,Total hip arthroplasty - Abstract
Background Mobility technicians (MTs) demonstrate value in constraining the cost of total joint replacement procedures. MTs are certified medical assistants with specialized ambulation/gait training who work under the direction of the nursing staff to meet patient mobilization demands in hospital wards. This study analyzed their impact on primary total hip arthroplasty (THA). Methods Data were retrospectively reviewed from both the time before and the time after MTs were introduced to the hospital for demographic information (ie, age, gender, race, and payer) and clinical measures (ie, length of stay and discharge disposition). The control group was treated and mobilized according to standard physical therapy and nursing staff protocols. Study group subjects had access to the MTs at the direction of their registered nurse. Included subjects underwent a primary THA procedure for arthritic conditions or hip fractures, or for conversion from a previous hip surgery. Excluded were subjects who underwent procedures for revision, bilateral, or hip resurfacing procedures. Results The study and control groups included 542 and 1297 subjects, respectively. They shared a median length of stay of 2 days (P = .121). More study group subjects were discharged home than were their control group counterparts (91.51%-87.43%, P = .012). Cost analysis revealed an annual savings of $119,794.50 in total first post-acute care (ie, the period spent at a patient’s initial discharge disposition level) costs to the institution. Therefore, MTs would need to successfully treat only 5 patients annually to recoup a savings equivalent to their salary. Conclusion MTs support the recovery of THA patients in the hospital, in turn optimizing their discharge disposition. Institutions may experience a financial benefit in a bundled payment system, in which avoiding costly rehab facilities may result in savings over the episode.
- Published
- 2020
- Full Text
- View/download PDF
26. Updated Analysis of the Oncology Section of the OITE from 2007 to 2019
- Author
-
Christopher Mazzei, Laura Sonnylal, Filippo Romanelli, Tyler Hoskins, Rohan Sampat, Jay N. Patel, James C. Wittig, and David Goyette
- Subjects
Oncology ,medicine.medical_specialty ,Joint surgery ,Medical knowledge ,Descriptive statistics ,business.industry ,Public Health, Environmental and Occupational Health ,Evidence-based medicine ,03 medical and health sciences ,0302 clinical medicine ,030220 oncology & carcinogenesis ,Internal medicine ,Radiological weapon ,Orthopedic surgery ,medicine ,Oncology Residency ,030212 general & internal medicine ,business ,Curriculum - Abstract
The Orthopaedic In-Training Exam (OITE) is administered annually to orthopedic surgery residents to assess their medical knowledge. The authors provide a comprehensive review of the orthopedic oncology portion of the exam in order to aid residents in preparation for future in-training and licensing examinations as well as to help guide oncology residency education curriculum. All of the orthopedic oncology questions on the OITE from 2007 to 2019 were reviewed. Analysis included (1) the number of oncology questions each year, (2) question topic, (3) question taxonomy (knowledge versus interpretation), (4) the type of imaging modalities (radiological, histological), (5) most commonly cited references, and (6) level of evidence. Descriptive statistics were utilized to compare means between variables. From 2007 to 2019, there was a total of 292 tumor-related questions with a mean of 22.5 tumor-related questions (range 19–28) per year. Of the questions, 54.8% pertained to malignant tumors and 45.2% to benign tumors. Assessment of question taxonomy showed that 79.8% of questions required interpretation of imaging and analysis of the information provided versus 20.2% of questions being knowledge recall type. Of the questions, 76.7% required interpretation of radiological images, pathological images, or both. Orthopaedic Knowledge Update, Journal of the American Academy of Orthopaedic Surgeons, and Journal of Bone and Joint Surgery were the three most commonly cited question sources. Only 29 (9.84%) oncology questions over the past 13 years have been supported by level I or II sources of evidence. Better understanding of the OITE make-up, question distribution, and number and style of question, reference sources can improve an orthopedic residents’ performance as well as better guide educational curriculum to prepare residents in their orthopedic oncology education.
- Published
- 2020
- Full Text
- View/download PDF
27. Five‐Year Follow‐Up of Coronary Microvascular Dysfunction and Coronary Artery Disease in Systemic Lupus Erythematosus: Results From a Community‐Based Lupus Cohort
- Author
-
Daniel J. Wallace, Mariko L. Ishimori, C. Noel Bairey Merz, Daniel S. Berman, Janet Wei, Louise Thomson, Jay N. Schapira, Vaneet K. Sandhu, and Michael H. Weisman
- Subjects
030203 arthritis & rheumatology ,medicine.medical_specialty ,Lupus erythematosus ,Systemic lupus erythematosus ,business.industry ,Unstable angina ,medicine.disease ,Chest pain ,Coronary artery disease ,03 medical and health sciences ,Pericarditis ,0302 clinical medicine ,Rheumatology ,Internal medicine ,Cohort ,medicine ,Cardiology ,medicine.symptom ,business ,Cohort study - Abstract
Objective The present study was undertaken to investigate prospective change in the prevalence of coronary microvascular dysfunction (CMD) and obstructive coronary artery disease (CAD) in a cohort of subjects with systemic lupus erythematosus (SLE) initially evaluated for anginal chest pain (CP). Prior work documented a relatively high prevalence of CMD in the absence of obstructive CAD in subjects with SLE. Methods Twenty female SLE subjects with CP who underwent stress cardiac magnetic resonance imaging (CMRI) and coronary computed tomography angiography at baseline were reevaluated at 5 years. Results Seventeen subjects (85%) were available and reenrolled, of which 11 (65%) had persistent CP at follow-up. Fourteen subjects had complete follow-up CMRI, of which 36% (n = 5) demonstrated CMD at follow-up. Further, 25% (1 of 4) of the originally abnormal myocardial perfusion reserve index (MPRI) findings at baseline were lower at follow-up, while 2 additional abnormal MPRI findings at follow-up were noted in previously normal MPRI results. The prevalence of CMD and nonobstructive/obstructive CAD both was unchanged between baseline and follow-up, respectively (both P values not significant). During follow-up, 33% of subjects (5 of 15) had adverse cardiac outcomes, including pericarditis, unstable angina, or intracranial aneurysm clipping procedure. Conclusion At the 5-year follow-up of SLE subjects with CP who were evaluated at baseline and follow-up, a majority had persistent CP, and nearly one-half had similar or worse myocardial perfusion consistent with CMD without obstructive CAD. These findings propose an alternative explanation for CP in SLE subjects compared to the more common SLE-related accelerated obstructive CAD accounting for CP and adverse outcomes. These findings support further studies of CMD as an etiology for cardiac morbidity and mortality in SLE.
- Published
- 2020
- Full Text
- View/download PDF
28. Quarantine, isolation and lockdown: in context of COVID-19
- Author
-
Jay N Shah, Jenifei Shah, and Jesifei Shah
- Subjects
Coronavirus disease 2019 (COVID-19) ,Isolation (health care) ,business.industry ,Social distance ,media_common.quotation_subject ,Refugee ,Internet privacy ,Wage ,Context (language use) ,law.invention ,law ,Political science ,Quarantine ,China ,business ,media_common - Abstract
Quarantine and lockdown, combined with restriction to the movement of people, along with measures like universal use of masks, social distancing, tracking, testing, isolation and specialized centers to manage COVID-19 patients, have been successful in the control and spread of the virus in China and most Asian countries, unlike in Europe and America. This review is written to provide information on quarantine, isolation and lockdown in the context of COVID-19 management. The quarantine and lockdown from historical, socio-cultural, and its effect on special circumstances, for example, the internal and international migrants, daily wage workers, refugees, and the ways in which countries have managed this issue, including the measures taken by Nepal to manage the quarantine and lockdown is briefly presented in this review. Keyword: COVID-19, isolation, lockdown, Nepal, quarantine, face masks, social distancing
- Published
- 2020
- Full Text
- View/download PDF
29. Revisit the hospital policy in the era of COVID-19
- Author
-
Rano Mal Piryani, Suneel Piryani, and Jay N Shah
- Subjects
Chest ultrasound ,medicine.medical_specialty ,Coronavirus disease 2019 (COVID-19) ,business.industry ,Dry cough ,Interstitial oedema ,Psychological intervention ,Context (language use) ,law.invention ,law ,Emergency medicine ,Medicine ,Infection control ,business ,Ground glass - Abstract
Patient with recent history of dry cough, fever and breathlessness (influenza-like or severe acute respiratory illness) without alternative explanation/diagnosis needs to be managed as COVID-19 unless proved otherwise. Suspected COVID-19 patient having fever and recent loss of taste and smell be tested for COVID-19. Patient with severe acute respiratory illness of unknown aetiology be tested for COVID-19. Patient with bilateral consolidation on chest X-ray or ground glass appearance on chest CT or interstitial oedema on chest ultrasound (not fully explained by volume overload) be tested for COVID-19 in moderate to high risk communities/countries. Suspected COVID-19 patients with lymphopenia, high ESR or rise in C-reactive protein and suspected of viral fevers be tested for COVID-19. Screening of pregnant women for COVID-19 with rapid testing preferably with Elisa in moderate to high risk communities/countries. Screening with rapid testing preferably with Elisa prior to invasive interventions, including operations, in moderate to high risk communities/countries. Limit the exposure of hospital staff who are susceptible to develop severe complications of COVID-19. Hospitals provide PPE to staff depending upon exposure as per international/national/local guidelines. Hospitals implement infection prevention control measures meticulously in context of COVID-19.
- Published
- 2020
- Full Text
- View/download PDF
30. Nepal’s Response to Contain COVID-19 Infection
- Author
-
Rano Mal Piryani, Suneel Piryani, and Jay N Shah
- Subjects
Adult ,Coronavirus disease 2019 (COVID-19) ,Pneumonia, Viral ,Psychological intervention ,Disease Outbreaks ,law.invention ,Betacoronavirus ,Young Adult ,03 medical and health sciences ,0302 clinical medicine ,Nepal ,law ,Pandemic ,Quarantine ,Humans ,Medicine ,030212 general & internal medicine ,Socioeconomics ,China ,Pandemics ,Aged ,Government ,SARS-CoV-2 ,business.industry ,COVID-19 ,Outbreak ,General Medicine ,Middle Aged ,Coronavirus ,Landlocked country ,Coronavirus Infections ,business ,030217 neurology & neurosurgery - Abstract
Nepal is a landlocked country bordering two most populous countries, India and China. Nepal shares open border with India from three sides, east, south and west. And, in north with China, where the novel coronavirus infection (CVOVID-19) began in late December 2019. The first confirmed imported case in Nepal was reported in 2nd week of January 2020. The initial response of Nepal to COVID-19 were comparably slow but country geared efforts after it was declared a ‘global pandemic’ by WHO on 11 March, 2020. Government of Nepal’s steps from 18 March, 2020 led to partial lock down and countrywide lockdown imposed on 24 March, 2020. Government devised comprehensive plan on 27 March, 2020 for quarantine for peoples who arrived in Nepal from COVID-19 affected countries. This article covers summary of global status, South Asian Association of Regional Cooperation (SAARC) status, and Nepal’s response to contain COVID-19 infection discussed under three headings: Steps taken before and after WHO declared COVID-19 a global pandemic and lab services regarding detection of COVID-19. Nepal has documented five confirmed cases of COVID-19 till the end of March 2020, first in second week of 15 January, 2020 and 2nd case 8-weeks thereafter and 3rd case two days later, 4th on 27 March and 5th on 28 March. Four more cases detected during first week of April. Non-Pharmacological interventions like social distancing and excellent personal habits are widely practiced. Country has to enhance testing and strengthen tracing, isolation and quarantine mechanism and care of COVID-19 patients as Nepal is in risk zone because of comparably weak health system and porous borders with India. The time will tell regarding further outbreak and how it will be tackled.Keywords: COVID-19; lockdown; Nepal; pandemic; response
- Published
- 2020
- Full Text
- View/download PDF
31. A case of pseudo-appropriate shock
- Author
-
Neal J. Ferrick, John D. Fisher, Andrew Krumerman, and Jay N. Gross
- Subjects
medicine.medical_specialty ,Inappropriate shock ,Slow VT ,business.industry ,medicine.medical_treatment ,Case Report ,Ventricular tachycardia ,Implantable cardioverter-defibrillator ,medicine.disease ,Subcutaneous ICD ,Internal medicine ,Shock (circulatory) ,medicine ,Cardiology ,Ventricular arrhythmia ,medicine.symptom ,Cardiology and Cardiovascular Medicine ,business ,Arrhythmia - Published
- 2020
32. Early cardiovascular structural and functional abnormalities as a guide to future morbid events
- Author
-
Lynn Hoke, Claire Carlson, Natalia Florea, Daniel Duprez, Jay N. Cohn, Sue Duval, Joy Lee, and Gregory A Grandits
- Subjects
Adult ,Male ,Battery (electricity) ,medicine.medical_specialty ,Epidemiology ,Future risk ,030204 cardiovascular system & hematology ,Functional health ,Risk Assessment ,03 medical and health sciences ,0302 clinical medicine ,Predictive Value of Tests ,Risk Factors ,medicine ,Humans ,Intensive care medicine ,030304 developmental biology ,0303 health sciences ,business.industry ,Middle Aged ,Predictive value ,Cardiovascular Diseases ,Female ,Cardiology and Cardiovascular Medicine ,business ,Forecasting - Abstract
Aims Our aim was to evaluate the predictive value of a battery of 10 non-invasive tests of cardiovascular structural and functional health on the future risk of cardiovascular morbid events. Methods and Results A total of 1900 asymptomatic adults concerned about their risk for cardiovascular disease underwent non-invasive assessment with 10 tests of vascular and cardiac structure and function. A disease score (DS) was calculated for each individual based on these 10 tests. Follow-up (mean 9.2 years) for cardiovascular morbidity and mortality was available for 1442 individuals (mean age 53.2 years, 48.2% women). Those in the lowest DS tertile (0–2) experienced 0.16 cardiovascular events per 100 patient-years (PY), those in the middle tertile (3–5) experienced 0.86 events per 100 PY, and those in the highest tertile (6+) experienced 1.3 events per 100 PY (p Conclusions Assessing the biological disease process in the arteries and heart of asymptomatic adults provides a guide to the risk of a future cardiovascular morbid event. Larger and longer studies are needed to determine whether risk factor algorithms, the severity of the biological process or some combination is the optimal method for identifying individuals in need of intervention to delay morbid events.
- Published
- 2020
- Full Text
- View/download PDF
33. Addressing Antibiotic Hip Spacer Instability via Hybrid Screw-cement Fixation of a Constrained Liner and Cement-rebar Interface Techniques
- Author
-
Richard A Pizzo, Jay N. Patel, Frank A. Liporace, and Richard S. Yoon
- Subjects
Reoperation ,musculoskeletal diseases ,Prosthesis-Related Infections ,Arthroplasty, Replacement, Hip ,medicine.medical_treatment ,Bone Screws ,Rebar ,Periprosthetic ,Dentistry ,medicine.disease_cause ,Weight-bearing ,law.invention ,03 medical and health sciences ,Fixation (surgical) ,Postoperative Complications ,0302 clinical medicine ,law ,Humans ,Medicine ,Orthopedics and Sports Medicine ,Cement ,030222 orthopedics ,Femur fracture ,business.industry ,Bone Cements ,030229 sport sciences ,Combined Modality Therapy ,Arthroplasty ,Anti-Bacterial Agents ,Surgery ,Cement fixation ,business - Abstract
Prosthetic joint infection is a challenging and devastating complication after total hip arthroplasty. The benchmark for treatment remains two-stage revision arthroplasty, in which an antibiotic-impregnated spacer is used to eradicate the infection. Although several types of spacer constructs have been described, they have historically been associated with high rates of mechanical complications, namely, dislocation, spacer fracture, and periprosthetic femur fracture. Spacer dislocation is the most common, with reported rates as high as 41%. Here, the authors present a surgical technique to improve the mechanical stability of an articulating hip spacer via a hybrid screw-cement fixation technique that allows for joint motion and weight bearing during the treatment period while minimizing the risk of mechanical failure. An additional technique is described to address acetabular bone loss, which has been associated with a higher spacer dislocation rate, through a cement-rebar interface construct.
- Published
- 2020
- Full Text
- View/download PDF
34. The first use of a rotating mechanical dilator sheath for S-ICD coil extraction
- Author
-
Jeremy Miles, Kavisha Patel, Jay N. Gross, Xiao Dong Zhang, and Nicola Tarantino
- Subjects
medicine.medical_specialty ,TightRail ,business.industry ,Defibrillation ,medicine.medical_treatment ,Case Report ,030204 cardiovascular system & hematology ,Inappropriate shocks ,Pacemaker leads ,Surgery ,03 medical and health sciences ,0302 clinical medicine ,Extraction techniques ,S-ICD ,Electromagnetic coil ,Dilator ,RC666-701 ,Medicine ,Diseases of the circulatory (Cardiovascular) system ,In patient ,Mechanical dilator sheath ,030212 general & internal medicine ,Cardiology and Cardiovascular Medicine ,business - Abstract
Over the last decade, subcutaneous implantable cardioverter-defibrillator (S-ICD) implantation has gained significant momentum for the prevention of sudden cardiac death. This device has been implanted in more than 19,000 patients worldwide.1 Given their ability to deliver defibrillation while leaving the heart and vasculature untouched, S-ICDs have emerged as an appealing alternative to conventional transvenous ICDs. Supporting the notion that transvenous leads are the “Achilles heel” of traditional ICDs, a recent meta-analysis2 demonstrated a significantly lower rate of lead-related complications in patients implanted with S-ICDs compared to transvenous ICDs. However, acute and chronic complications still do occur with S-ICDs, sometimes requiring device extraction. There is an increasing necessity to establish safe and effective methods for device extraction in the event of untoward complications. Currently, data describing the challenges encountered during S-ICD extraction are scarce. Of the various components, extraction of the subcutaneous coil can be particularly difficult. The TightRail (Spectranetics Corp, Colorado Springs, CO) rotating mechanical dilator has emerged as a novel tool for the extraction of transvenous ICD and pacemaker leads in the past 5 years, with early reports revealing encouraging results.3, 4 The purpose of this case report is to describe the use of a mechanical dilator sheath for extraction of an S-ICD coil. To our knowledge, this is the first case in the literature reporting the safety and efficacy of TightRail for successful extraction of a chronically implanted S-ICD coil.
- Published
- 2020
35. Outcomes in Multidisciplinary Team-based Approach in Geriatric Hip Fracture Care: A Systematic Review
- Author
-
Richard S. Yoon, Frank A. Liporace, David S Klein, Swathy Sreekumar, and Jay N. Patel
- Subjects
medicine.medical_specialty ,MEDLINE ,Multidisciplinary team ,Patient Readmission ,Time-to-Treatment ,03 medical and health sciences ,0302 clinical medicine ,Multidisciplinary approach ,medicine ,Humans ,Orthopedics and Sports Medicine ,Patient Care Team ,Geriatrics ,030222 orthopedics ,Hip fracture ,Heterogeneous group ,Hip Fractures ,business.industry ,Outcome measures ,030229 sport sciences ,Length of Stay ,medicine.disease ,Physical therapy ,Surgery ,Lower cost ,business - Abstract
Introduction This systematic review analyzes the literature on the treatment of geriatric hip fractures by a multidisciplinary hip fracture service including geriatricians/internists and orthopaedic surgeons and what impact this has on patient outcomes. Methods A systematic review of several databases was conducted according to PRISMA guidelines. Studies comparing an orthopaedic-led care model versus a coordinated orthogeriatrics care model or a geriatrics-led care model to treat hip fractures with reported outcomes for time to surgery, length of stay, readmission rates, and postoperative mortality were included. Results Seventeen articles fitting the inclusion criteria were included. Differences between the results of an orthopaedic-led care model versus a coordinated orthogeriatrics care model or a geriatrics-led care model were assessed using chi-squared tests. With patients admitted under a coordinated orthogeriatrics care model or a geriatrics-led care model, there is a statistically significant decrease in time to surgery (P = 0.045), length of stay (P = 0.0036), and postoperative mortality rates (P = 0.0034). Conclusions Although a heterogeneous group of studies, the aggregate data from several studies using an orthogeriatrics care model or a geriatrics-led care model trend toward improvements across several clinical and cost-related outcome measures: decreased time to surgery, shorter length of stay, improved postoperative clinical outcomes, decreased mortality, and lower cost.
- Published
- 2020
- Full Text
- View/download PDF
36. Relation of Frailty to Cost for Patients Undergoing Transcatheter Aortic Valve Implantation
- Author
-
Mansoor Ahmad, Jay N Patel, Sudhir Mungee, Minchul Kim, Carl V. Asche, Sandeep Banga, and Marco Barzallo
- Subjects
Male ,medicine.medical_specialty ,Time Factors ,Transcatheter aortic ,Frail Elderly ,030204 cardiovascular system & hematology ,Single Center ,Risk Assessment ,Transcatheter Aortic Valve Replacement ,03 medical and health sciences ,0302 clinical medicine ,Risk Factors ,Internal medicine ,medicine ,Humans ,030212 general & internal medicine ,Geriatric Assessment ,Retrospective Studies ,Aged, 80 and over ,Frailty ,Adult patients ,business.industry ,Incidence ,Incidence (epidemiology) ,Follow up studies ,Retrospective cohort study ,Aortic Valve Stenosis ,Health Care Costs ,Costs and Cost Analysis ,Cardiology ,Female ,Illinois ,Cardiology and Cardiovascular Medicine ,business ,Follow-Up Studies - Abstract
Frailty is associated with significant morbidity and mortality for patients undergoing transcatheter aortic valve implantation (TAVI). In addition to clinical outcomes, cost is an important factor to inform clinical decision-making around TAVI. However, the association of frailty with cost is unknown. This study tested whether frailty was associated with cost for adult patients who underwent TAVI at a moderate-volume single center between December 2012 and April 2018 (n = 431). Frailty was determined from pre-TAVI clinical visits as a composite of 2 markers: 5-meter walk time (abnormal:6 seconds or unable to perform) and serum albumin (abnormal:3.5 g/dl). Patients were excluded if missing frailty assessment or covariate data (24). Cost data were derived from financial statements, and assigned at the department-level by charge code. Multivariable regression models were adjusted for age, gender, and procedural co-morbidities. Of 407 patients in the analytical sample (mean age 81 years, 49% female), 74 (18%) were determined to be frail. Adjusted mean total costs were $6,397 higher for frail patients ($78,823 vs $72,425, p = 0.042) compared with nonfrail. Higher total costs were driven by department-level charges associated with longer in-hospital length of stay (7.6 vs 3.3 days, p0.001): room, physical therapy, pharmacy, laboratory, supply, and imaging services. Providers must address frailty proactively to salvage the benefit associated with TAVI.
- Published
- 2020
- Full Text
- View/download PDF
37. A Survey on the Use of Data Clustering for Intrusion Detection System in Cybersecurity
- Author
-
Fan Wu, Jay N. Bhuyan, Binita Bohara, and Junhua Ding
- Subjects
Computer science ,Network security ,business.industry ,02 engineering and technology ,Intrusion detection system ,Computer security ,computer.software_genre ,Article ,020204 information systems ,0202 electrical engineering, electronic engineering, information engineering ,020201 artificial intelligence & image processing ,Cluster analysis ,business ,computer - Abstract
In the present world, it is difficult to realize any computing application working on a standalone computing device without connecting it to the network. A large amount of data is transferred over the network from one device to another. As networking is expanding, security is becoming a major concern. Therefore, it has become important to maintain a high level of security to ensure that a safe and secure connection is established among the devices. An intrusion detection system (IDS) is therefore used to differentiate between the legitimate and illegitimate activities on the system. There are different techniques are used for detecting intrusions in the intrusion detection system. This paper presents the different clustering techniques that have been implemented by different researchers in their relevant articles. This survey was carried out on 30 papers and it presents what different datasets were used by different researchers and what evaluation metrics were used to evaluate the performance of IDS. This paper also highlights the pros and cons of each clustering technique used for IDS, which can be used as a basis for future work.
- Published
- 2020
- Full Text
- View/download PDF
38. Differences in Outcome Between Open vs Laparoscopic Insertion of Ventriculoperitoneal Shunts
- Author
-
Jay N. Collins, Jessica R Burgess, Kevin M. Guy, and Aaron B. Lopacinski
- Subjects
medicine.medical_specialty ,medicine.diagnostic_test ,business.industry ,Operative Time ,Retrospective cohort study ,General Medicine ,Tertiary referral hospital ,Ventriculoperitoneal Shunt ,Surgery ,Postoperative Complications ,Cohort ,medicine ,Humans ,Laparoscopy ,Neurosurgery ,Vp shunt ,business ,Shunt (electrical) ,Abdominal surgery ,Hydrocephalus ,Retrospective Studies - Abstract
Background Abdominal access during ventriculoperitoneal (VP) shunt insertion has historically been obtained by neurosurgeons via an open abdominal approach. With recent advances in laparoscopy, neurosurgeons frequently consult general surgery for aid during the procedure. The goal of this study is to identify if laparoscopic assistance improves the overall outcomes of the procedure. Methods This retrospective study included all patients who underwent open or laparoscopic VP shunt placement between September 2012 and August 2020 at our tertiary referral hospital. Patient demographics, comorbidities, prior history of abdominal surgery, open vs. laparoscopic insertion, operation time, and complications within 30 days were obtained. Results Neurosurgery placed 107 shunts using an open abdominal technique and general surgery placed 78 using laparoscopy. The average OR time in minutes was 75.5 minutes for the open cohort and 61.8 for the laparoscopic cohort ( p = 0.006). In patients without a history of abdominal surgery, the average OR time in minutes was 79.4 in the open cohort and 57.1 in the laparoscopic cohort ( p = 0.015). The postoperative shunt infection rate was 10.2% in the open group and 3.8% in the laparoscopic group ( p = 0.077). Discussion Laparoscopic placement of VP shunts is a reasonable alternative to open placement and results in shorter OR times. There is also a trend toward few infections in the laparoscopic placement. There appears to be an advantage with a team approach and laparoscopic placement of the peritoneal portion of the shunt.
- Published
- 2021
39. Atypical Mycobacterial Tenosynovitis in the Setting of Adalimumab Use
- Author
-
Nilmarie Guzman, Kurt Wukitsch, and Jay N. Patel
- Subjects
medicine.medical_specialty ,musculoskeletal ,Tenosynovitis ,business.industry ,General Engineering ,Infectious Disease ,psoriasis ,Disease ,medicine.disease ,tenosynovitis ,Dermatology ,Ulcerative colitis ,nontuberculous mycobacterium ,Rheumatology ,adalimumab ,Rheumatoid arthritis ,Psoriasis ,Internal Medicine ,Adalimumab ,Medicine ,Tumor necrosis factor alpha ,business ,Complication ,medicine.drug - Abstract
Tumor necrosis factor-alpha (TNF-α) inhibitors indicated in the management of psoriasis, rheumatoid arthritis, ulcerative colitis, Crohn’s disease, and other autoimmune diseases have been associated with the development of mycobacterial and other opportunistic infections. The majority of mycobacterial infections diagnosed in patients taking TNF-α inhibitors are secondary to Mycobacterium tuberculosis. Atypical mycobacteria have also been identified in this patient population, most commonly manifested by pulmonary or disseminated infections. Extra-pulmonary manifestations such as bone and joint infections are rare. We describe a case of atypical mycobacterial tenosynovitis in the setting of adalimumab use in a patient with psoriasis. This is a rarely reported complication that one should be aware of when prescribing these medications.
- Published
- 2021
- Full Text
- View/download PDF
40. Eye Melanoma Cancer Detection and Classification Using CNN
- Author
-
Vaishnavi Patel, Sheshang Degadwala, Harsh S Dave, Dhairya Vyas, and Jay N. Mehta
- Subjects
Artificial neural network ,business.industry ,Computer science ,Pattern recognition ,medicine.disease ,Convolutional neural network ,Convolution ,Identification (information) ,Classifier (linguistics) ,Eye melanoma ,Median filter ,medicine ,Artificial intelligence ,business ,Image resolution - Abstract
However, eye cancer may be the rare disease that matches malignancy; it is the most prevalent form of cancer. It is curable in many of the circumstances, equivalent to the alternative types of cancer, if correctly diagnosed, but the diagnosis approach is very complex and the most troubling difficulty for eye cancer care. This document introduces an automated technique for the identification of the skin of the eye, using a neural convolution network (CNN) with a grey victimisation conversion to top picture resolution. 200 samples pre-diagnosed square measurement based on the traditional data, resized and median filtered for low resolution batter image and ultimately supplied to the Convolution Neural Network specification. Although the planned technology requires a broad calculation, a accurate high rate of 92.5% is getting to exceed careful victimisation Convolution Neural Network classifier for classification of features and the extraction of the neural network can be used to extract options from the image..
- Published
- 2021
- Full Text
- View/download PDF
41. Regional Kidney Stone Detection and Classification In Ultrasound Images
- Author
-
Harsh S Dave, Sheshang Degadwala, Jay N. Mehta, Vaishnavi Patel, and Dhairya Vyas
- Subjects
business.industry ,Region of interest ,Computer science ,Feature (computer vision) ,Feature extraction ,Ultrasound ,Confusion matrix ,Pattern recognition ,Ultrasonic sensor ,Artificial intelligence ,Entropy (energy dispersal) ,business ,Object detection - Abstract
The ultrasound region of interest is a challenge since the textures and noises are diverse. The most common technique is the ultrasound scans to check for abnormalities in the kidney, in particular the presence of stones. Automatic ultrasonic object detection burns research fields and the study effort now under way is along the same line. Application that allows the physician to detect the stone area in the ultrasound picture has been designed. The practitioner needs to pick the location that is evaluated by the suggested stone presence system. The extraction feature is used to areas that might contain stone. Different characteristics, such contrast, second angular moment, entropy and correlation, are employed. The KNN classification is used for training picture dataset categorization. Classification system total accuracy is about 91%. The confusion matrix will also assess the complexity and exactness of the system being suggested.
- Published
- 2021
- Full Text
- View/download PDF
42. Prospective genomic surveillance reveals cryptic MRSA outbreaks with local to international origins among NICU patients
- Author
-
Jessica W. Crothers, Sai Laxmi Gubbala Venkata, Maria Hoffmann, William J. Wolfgang, Michael Klompas, Jay N. Worley, Victor Jayeola, Lynn Bry, and Marc W. Allard
- Subjects
medicine.medical_specialty ,Patient population ,business.industry ,MRSA colonization ,Transmission (medicine) ,SCCmec ,Resistant phenotype ,Internal medicine ,Medicine ,Infection control ,Outbreak ,Colonization ,business - Abstract
MRSA infections cause significant morbidity and mortality in neonates. Clinical testing and routine surveillance screening identified an increase in neonates with MRSA colonization and infection which triggered prospective genomic surveillance. Here we show the complex transmission dynamics of MRSA in a NICU setting. Analyses revealed concurrent transmission chains affecting 16 of 22 MRSA-colonized patients (68%), and 3.1% of all NICU patients (n=517). Prematurity and longer lengths of stay increased risks for colonization. Intervals of up to 7 months occurred among some cluster-related isolates. 3 of 22 MRSA-colonized patients developed invasive infections with the colonizing strain. Comparisons with 21,521 isolates in the NCBI Pathogen Detection Resource revealed NICU strains to be distinct from MRSA seen locally and internationally. Integration of international strain datasets in analyses increased the resolution of strain clusters and helped rule-out suspected transmission events. Analyses also identified sequence type 1535 isolates, emergent in the Middle East, carrying a unique SCCmec with fusC and aac(6’)-Ie/aph(2’’)-1a that provided a multi-drug resistant phenotype. NICU genomic surveillance identified cryptic MRSA colonization events, including NICU-endemic strains not linked with local hospital or international clusters, and has rich potential to guide improvements in infection prevention for this vulnerable patient population.
- Published
- 2021
- Full Text
- View/download PDF
43. Briefing: Sustainable Management of Municipal Solid Waste without Food Waste
- Author
-
Bruno Bezerra de Souza and Jay N. Meegoda
- Subjects
Food waste ,Environmental Engineering ,Municipal solid waste ,Waste management ,Sustainable management ,Sustainability ,Environmental Chemistry ,Business ,General Environmental Science - Abstract
This paper discusses the feasibility of sustainable management of municipal solid waste without food waste. Many governments, states and cities are aware of the adverse impacts of food waste on the...
- Published
- 2020
- Full Text
- View/download PDF
44. Laparoscopic surgery for intestinal obstruction in children due to water absorbing gel beads
- Author
-
Jay N Shah, Hou Guangjun, Zhang Xianwei, Geng Xianjie, and Zhou Liang
- Subjects
Laparoscopic surgery ,medicine.medical_specialty ,Leak ,medicine.diagnostic_test ,Wound dehiscence ,business.industry ,medicine.medical_treatment ,digestive, oral, and skin physiology ,Postoperative recovery ,Anastomosis ,medicine.disease ,Surgery ,medicine ,Ingestion ,Foreign body ,Laparoscopy ,business - Abstract
Introductions: Super absorbent polymer gel bead (SAPGB) is increasingly available as toys for children. When ingested it swells by absorbs water and leads to acute intestinal obstruction. Diagnosis and surgery is challenging as its radiolucent, fragile and slippery. We present outcome of our innovative technique of stabilization and removal SAPGBs by laparoscopy minimal invasive surgery (lap-MIS). Methods: This retrospective analyse of outcome of lap-MIS in intestinal obstruction caused by ingestion of foreign body, the SAPGBs, in children who were managed at Children's Hospital Affiliated to Zhengzhou University, China. The outcome variables included removal of SAPGBs, length of hospital stay and postoperative occurrence of anastomotic leak, wound infection, wound dehiscence, re-surgery, or mortality. Results: There were 15 children, male 9 (60%), average age 2 years, and duration of ingestion of SAPGBSs 1.5 days (range 2-4 days), parents gave history of accidental ingestion in 6 (40%). All children had uneventful postoperative recovery after lap-MIS removal of foreign body with no wound infection, anastomotic leak, re-surgery or mortality. Average hospital stay was 4 days (range 3 to 5 days). Conclusions: We had successful outcome lap-MIS with our innovative technique to stabilize and extract foreign bodies, the super water absorbent gel beads, ingested by children. Keywords: children, foreign body, gastrointestinal obstruction, laparoscopy minimal invasive surgery, super absorbent polymer gel beads
- Published
- 2019
- Full Text
- View/download PDF
45. Perioperative outcomes after open radical cystectomy for muscle invasive bladder cancer
- Author
-
Pukar Maskey, Jay N Shah, Anjit Phuyal, and Samir Shrestha
- Subjects
medicine.medical_specialty ,Bladder cancer ,Blood transfusion ,business.industry ,Wound dehiscence ,Urinary system ,medicine.medical_treatment ,Retrospective cohort study ,Perioperative ,medicine.disease ,Surgery ,Cystectomy ,Transitional cell carcinoma ,medicine ,business - Abstract
Introductions: Radical cystectomy with bilateral pelvic lymphadenectomy is a primary intervention for muscle invasive or refractory, high grade Ta, T1, Tis bladder cancer. Owing to its major undertaking, patient succumbs to infection and various morbidities. This study was to assess the perioperative outcomes and complications of radical cystectomy. Methods: This retrospective study analyzed the perioperative outcome (early mortality within 30 days, length of stay, requirement of blood transfusion) of radical cystectomy in patients with bladder cancer during four years at Patan Hospital, Patan Academy of Health Sciences, Lalitpur, Nepal. Ethical approval was obtained. Study variables included patient’s demographics, presenting symptoms, tumor types and configuration, need for blood transfusion, length of surgery, pathological stages, types of urinary diversions, hospital stay, early (
- Published
- 2019
- Full Text
- View/download PDF
46. Clinical characteristics and short-term outcomes for rabbits with signs of gastrointestinal tract dysfunction: 117 cases (2014–2016)
- Author
-
Jonathan M. Babyak, Jay N. Gladden, Christopher Lambert, Jennifer E. Graham, and Kimberly M. Oparil
- Subjects
Gastrointestinal tract ,General Veterinary ,medicine.diagnostic_test ,Gastrointestinal Diseases ,business.industry ,Medical record ,Retrospective cohort study ,Physical examination ,Hypothermia ,Disease ,Anesthesia ,Animals ,Medicine ,Clinical significance ,Prospective Studies ,Rabbits ,business ,Prospective cohort study ,Feces ,Retrospective Studies - Abstract
OBJECTIVE To describe the clinical findings and short-term outcomes for rabbits with signs of gastrointestinal tract dysfunction or rabbit gastrointestinal syndrome (RGIS). ANIMALS 117 client-owned rabbits. PROCEDURES The electronic medical records database of a veterinary teaching hospital was searched to identify rabbits that were examined because of altered or absent food intake and decreased or absent fecal output between June 1, 2014, and June 30, 2016. For each rabbit, information extracted from the record included history of prior episodes of gastrointestinal tract dysfunction, signalment, physical examination and diagnostic test results, and outcome. RESULTS 117 of the 484 (24%) rabbits examined at the hospital during the study period met the inclusion criteria and were enrolled in the study. Fifty-nine and 58 rabbits were managed on an inpatient and outpatient basis, respectively. Gastrointestinal stasis without overt obstruction was diagnosed for 43 rabbits on the basis of abdominal radiographic, ultrasonographic, or necropsy results. Many rabbits had concurrent disease and biochemical abnormalities. Fifteen, 18, and 84 rabbits died, were euthanized, and survived to hospital discharge, respectively. Rabbits that were hypothermic (rectal temperature, ≤ 36.6°C [97.9°F]) during the initial examination were 5 times as likely to die or be euthanized as were euthermic rabbits, after controlling for potential confounders. CONCLUSIONS AND CLINICAL RELEVANCE Results indicated that the prognosis was generally good for rabbits with signs of RGIS unless they were hypothermic during initial examination. Prospective studies are warranted to further elucidate and characterize RGIS and assess the efficacy of various treatments and outcomes for affected rabbits.
- Published
- 2019
- Full Text
- View/download PDF
47. Thrombosis risk factors in PIK3CA‐related overgrowth spectrum and Proteus syndrome
- Author
-
Jay N. Lozier, Neal L. Oden, Jasmine Burton-Akright, Anjali Taneja, Leslie G. Biesecker, Kim M. Keppler-Noreuil, and Julie C. Sapp
- Subjects
Adult ,Male ,Pathology ,medicine.medical_specialty ,Adolescent ,Class I Phosphatidylinositol 3-Kinases ,Venography ,AKT1 ,Pilot Projects ,Thrombomodulin ,Article ,Proteus Syndrome ,Young Adult ,Genetics ,medicine ,Humans ,Genetic Predisposition to Disease ,Prospective Studies ,Child ,Growth Disorders ,Genetics (clinical) ,medicine.diagnostic_test ,business.industry ,Infant ,Thrombosis ,Middle Aged ,medicine.disease ,Intercellular adhesion molecule ,Proteus syndrome ,Deep vein thrombosis (DVT) ,Child, Preschool ,Female ,business ,CLOVES syndrome - Abstract
Increased risk of thromboembolism has been recognized in individuals with mosaic overgrowth disorders, Proteus syndrome (PS) and PIK3CA-related overgrowth spectrum (PROS), including Klippel–Trenaunay syndrome and CLOVES syndrome. PS and PROS have distinct, yet overlapping clinical findings and are caused by somatic pathogenic variants in the PI3K/AKT gene signaling pathway. PS is caused by a single somatic activating AKT1 c.49G > A p.E17K variant while PROS can be caused one of multiple variants in PIK3CA. The role of prothrombotic factors, endothelial cell adhesion molecules, and vascular malformations in both PS and PROS have not been previously investigated. A pilot study of prospective clinical and laboratory evaluations with the purposes of identifying potential risk factors for thrombosis was conducted. Doppler ultrasounds and magnetic resonance angiogram/ venography (MRA/MRV) scans identified vascular malformations in PS and PROS that were not appreciated on physical examination. Abnormal D-dimers (0.60–2.0 mcg/ml) occurred in half of individuals, many having vascular malformations, but no thromboses. Soluble vascular endothelial markers, including thrombomodulin, soluble vascular adhesion molecule (sVCAM), soluble intercellular adhesion molecule (sICAM), E-selectin, and P-selectin were significantly higher in PS and PROS compared to controls. However, no single attribute was identified that explained the risk of thrombosis. Predisposition to thrombosis is likely multifactorial with risk factors including chronic stasis within vascular malformations, stasis from impaired mobility (e.g., following surgery), decreased anticoagulant proteins, and effects of AKT1 and PIK3CA variants on vascular endothelium. Based on our findings, we propose clinical recommendations for surveillance of thrombosis in PS and PROS.
- Published
- 2019
- Full Text
- View/download PDF
48. Bedside Incentive Spirometry Predicts Risk of Pulmonary Complication in Patients with Rib Fractures
- Author
-
Jessica R Burgess, Jay N. Collins, Craig A Sadler, and Kristen Dougherty
- Subjects
Spirometry ,medicine.medical_specialty ,medicine.diagnostic_test ,business.industry ,Point-of-care testing ,medicine.medical_treatment ,Pulmonary Complication ,030208 emergency & critical care medicine ,Retrospective cohort study ,General Medicine ,Surgery ,03 medical and health sciences ,0302 clinical medicine ,030220 oncology & carcinogenesis ,Relative risk ,Medicine ,Intubation ,business ,Complication ,Risk assessment - Abstract
This retrospective chart review demonstrates the relationship between bedside incentive spirometry (ICS) volumes and risk of pulmonary complications. Two hundred patients admitted for rib fractures between April and October 2016 were reviewed. The inclusion criteria were age 18–98 years, diagnosis of rib or sternal fractures, and no procedures requiring postoperative intubation within 48 hours of admission. The exclusion criteria were intubation before arrival, unable to participate in ICS, or previous tracheostomy. ICS volumes recorded in daily progress notes were collected. Of 200 charts reviewed, 154 met the inclusion criteria. In all, 25 endured at least one pulmonary complication. The average ICS on admission was 1355 cc. Patients who did not experience a complication had significantly higher admission ICS volumes than those who did (1441 ± 660 cc vs 920 ± 451 cc, P = 0.0003). They also achieved higher volumes at discharge (1705 ± 662 cc vs 1211 ± 453 cc, P = 0.006). The groups had similar demographics. An admission ICS volume
- Published
- 2019
- Full Text
- View/download PDF
49. Application of the Diffused Double Layer Theory to Nanobubbles
- Author
-
Jay N. Meegoda, Shaini Aluthgun Hewage, and Janitha H. Batagoda
- Subjects
Double layer (biology) ,Materials science ,business.industry ,02 engineering and technology ,Surfaces and Interfaces ,Electrolyte ,010402 general chemistry ,021001 nanoscience & nanotechnology ,Condensed Matter Physics ,01 natural sciences ,0104 chemical sciences ,Electrochemistry ,Optoelectronics ,General Materials Science ,0210 nano-technology ,business ,Spectroscopy - Abstract
Nanobubbles have electrically charged interfaces; hence, the diffused double layer theory can be applied to explain the behavior of nanobubbles in different electrolytic solutions. In this research, oxygen nanobubbles were generated in NaCl solutions of different concentrations, and bubble size and ζ potentials were measured just after the generation and after 1 week. The measured data and diffused double layer theory were used to compute the surface charge density, the potential due to the surface charge, and the interaction energy between bubbles. With the increased NaCl concentration, bubble size, surface charge density, and the number of negative charges increased, while the magnitude of ζ potential/surface potential, double layer thickness, internal pressure, and the electrostatic repulsion force decreased. The same trend was observed after 1 week. The net total energy calculation for the 0.001 M NaCl solution showed that the bubble repulsion for an intermediate separation distance had a 6.99 × 10
- Published
- 2019
- Full Text
- View/download PDF
50. Screening surgical residents’ laparoscopic skills using virtual reality tasks: Who needs more time in the sim lab?
- Author
-
Katherine Peterson, Kenneth H. Perrone, Brett Wise, Anna Garren, Chembian Parthiban, Hossein Mohamadipanah, Jay N. Nathwani, and Carla M. Pugh
- Subjects
Adult ,Male ,medicine.medical_specialty ,Time Factors ,030230 surgery ,Virtual reality ,Risk Assessment ,03 medical and health sciences ,0302 clinical medicine ,Task Performance and Analysis ,Humans ,Mass Screening ,Medicine ,Computer Simulation ,Medical physics ,Correlational analysis ,Technical skills ,Simulation Training ,Curriculum ,Motor skill ,business.industry ,Ventral hernia repair ,Virtual Reality ,Internship and Residency ,Visualization ,Education, Medical, Graduate ,Motor Skills ,030220 oncology & carcinogenesis ,Quality Score ,Female ,Laparoscopy ,Surgery ,Clinical Competence ,business - Abstract
This study investigated the possibility of using virtual reality perceptual-motor tasks as a screening tool for laparoscopic ability. We hypothesized that perceptual-motor skills assessed using virtual reality will correlate with the quality of simulated laparoscopic ventral hernia repair.Surgical residents (N = 37), performed 2 virtual reality perceptual-motor tasks: (1) force matching and (2) target tracking. Participants also performed a laparoscopic ventral hernia repair on a simulator and final product quality score, and endoscopic visualization errors were calculated. Correlational analysis was performed to assess the relationship between performance on virtual reality tasks and laparoscopic ventral hernia repair.Residents with poor performance on force matching in virtual reality-"peak deflection" (r = -0.34, P.05) and "summation distance" (r = -0.36, P.05)-had lower final product quality scores. Likewise, poor performance in virtual reality-based target tracking-"path length" (r = -0.49, P.05) and "maximum distance" (r = -0.37, P.05)-correlated with a lower final product quality score.Our findings support the notion that virtual reality could be used as a screening tool for perceptual-motor skill. Trainees identified as having poor perceptual-motor skill can benefit from focused curricula, allowing them to hone personal areas of weakness and maximize technical skill.
- Published
- 2019
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.